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ABSTRACT OF THE DISSERTATION 
Regulation of metabolic stress-induced snoRNAs 
by 
Benjamin Steel Scruggs 
Doctor of Philosophy in Biology and Biomedical Sciences 
(Molecular Cell Biology) 
Washington University in St. Louis, 2012 
Professor Jean E. Schaffer, Chairperson 
 
Accumulation of excess lipid in non-adipose tissues is associated with oxidative 
stress and organ dysfunction and plays an important role in diabetic complications. 
While a number of stress responses have been implicated, the precise molecular 
mechanisms linking lipid accumulation and cellular dysfunction are not fully understood. 
To elucidate molecular events critical for lipotoxicity, we used retroviral promoter trap 
mutagenesis to generate mutant Chinese hamster ovary cell lines resistant to lipotoxic 
and oxidative stress. This approach uncovered a previously unsuspected role for small 
nucleolar RNAs (snoRNAs) as critical mediators of lipotoxic cell death. 
Herein we show that under lipotoxic conditions, intronic snoRNAs in the rpL13a 
gene accumulate in the cytosol during metabolic stress, suggesting that these non-
coding RNAs function non-canonically to target cytosolic RNAs. Moreover, we 
demonstrate that the rpL13a snoRNAs play a critical role in vivo in amplification of 
reactive oxygen species and downstream oxidative stress-mediated tissue injury. 
Study of independent mutants from our genetic screen not only identified a role 
for snoRNAs in lipotoxicity, but also provided new insights into the cellular machinery for 
xiii 
production of these non-coding RNAs. We demonstrate that the spliceosomal protein 
SmD3 plays a critical role in expression of intronic non-coding RNAs, including the 
rpL13a snoRNAs, by maintaining the abundance of snoRNA-containing intron lariats 
from which they are processed. Our findings indicate that this function may involve 
effects of SmD3 on small nuclear RNAs (snRNAs) U4 and U5.  
Finally, we demonstrate a link between superoxide induction and cytosolic 
snoRNA accumulation. Under lipotoxic conditions, superoxide induction precedes 
cytosolic snoRNA accumulation. Other chemical inducers of superoxide also cause the 
rpL13a snoRNAs to localize to the cytosol, and manipulation of superoxide dismutase 
demonstrates that superoxide levels directly correlate with cytosolic snoRNA 
expression.  
Together, our studies identify an important role for snoRNAs in metabolic stress 
responses. The rpL13a snoRNAs are essential for cell death in response to lipid 
overload through functions that are distinct from their canonical role in ribosomal RNA 
modification in the nucleolus. Moreover, these non-coding RNAs respond to chemical 
inducers of reactive oxygen species and thereby may contribute more broadly to 
disease pathogenesis that involves oxidative stress.  	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CHAPTER 1 
Introduction to Lipotoxicity 
 
Type 2 diabetes is a growing worldwide health concern 
 Metabolic syndrome, obesity, and type 2 diabetes are growing in prevalence at 
an astounding rate in the United States and around the world. Occurrence of type 2 
diabetes is increasing in both adult and juvenile populations. In 2011, the Centers for 
Disease Control estimated that 26 million Americans have type 2 diabetes and 79 
million have some form of metabolic syndrome, and those numbers are expected to 
double or triple by 2050 (National Diabetes Fact sheet 2011, online). Type 2 diabetics 
have increased risks for heart disease, stroke, hypertension, nephropathy, neuropathy, 
and retinopathy. In the United States, diabetes costs $174 billion annually, including 
$116 billion in direct medical expenses. Therefore, it is becoming increasingly important 
to understand the underlying causes of complications associated with diabetes. 
 
Lipotoxicity is a hallmark of metabolic disease 
Diabetes complications are likely related to the systemic metabolic abnormalities 
in this disease. While it is well appreciated that hyperglycemia contributes to diabetes 
pathogenesis, elevations in serum triglycerides and free fatty acids also play an 
important role in the pathogenesis of diabetic complications. Under physiological 
conditions, mammalian adipose cells internalize and store large quantities of lipid. 
However, under pathophysiological conditions, accumulation of fatty acids in non-
adipose tissues causes cell dysfunction and cell death that lead to impaired organ 
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function (112). This phenomenon, known as lipotoxicity, contributes to the pathogenesis 
of heart failure, renal dysfunction, steatohepatitis, and progressive pancreatic 
insufficiency (3, 46, 50, 96, 97). 
 
Mechanisms linking lipid overload to cell death 
In vitro models in which the media of cultured cells is supplemented with excess 
fatty acid have been used to probe metabolic and signaling pathways involved in the 
cellular response to lipid overload. In a time- and dose-dependent manner, long-chain 
saturated fatty acids induce apoptosis in a variety of cell types (11, 18, 61, 66, 124), and 
this response is enhanced by high glucose (20). Although lipid overload in non-adipose 
cells is initially buffered by cytoprotective triglyceride stores (60, 63), when the limited 
capacity for neutral lipid storage in non-adipose cells is exceeded, excess saturated 
fatty acids initiate several cellular stress response pathways. Fatty acid-induced 
endoplasmic reticulum stress can result in reactive oxygen species (ROS) generation 
(99). Independently, oxidative stress is induced in a variety of cell types through 
activation of NADPH oxidase, mitochondrial dysfunction due to remodeling of organelle 
membranes, and excessive cycles of oxidative phosphorylation (45, 82, 101). NADPH 
oxidase participates in palmitate-induced superoxide production (31) and is likely to 
spark a cascade of ROS production as ROS are rapidly interconverted (34). 
Dismutation of superoxide produces hydrogen peroxide. Subsequently, hydrogen 
peroxide will produce highly reactive hydroxyl radicals in the presence of metal ions 
through Fenton or Harber-Weiss reactions. Hydrogen peroxide can also be converted to 
hypochlorous acid in the presence of myeloperoxidase. Superoxide can also react with 
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nitric oxide to form another highly reactive molecule, peroxynitrite. Excessive ROS lead 
to detrimental consequences including protein carbonylation, lipid peroxidation, and 
DNA damage (14, 17, 76). Administration of antioxidants to cultured cells and animal 
models of lipotoxicity mitigates against lipotoxic cell death (8, 9, 56, 61), suggesting a 
central role for oxidative stress in lipotoxicity.  
 
Elucidating molecular mechanisms of lipotoxicity 
Despite identification of stress pathways involved in lipotoxicity, the precise 
molecular responses following lipid overload have yet to be elucidated. To identify 
genes critical for the cellular lipotoxic response, we performed a genetic screen in 
Chinese hamster ovary (CHO) cells, with mutagenesis by transduction with ROSAβgeo 
retrovirus at low multiplicity of infection to achieve, on average, one insertion per ten 
genomes. Although the integrated provirus contains a cDNA cassette for a β-
galactosidase-neomycin phosphotransferase fusion protein, it lacks its own promoter, 
and thus its transcript is expressed only if the retrovirus inserts downstream of an active 
promoter and splice donor site. Mutagenized cells that survived a round of neomycin 
selection were then treated for 48 h in media supplemented with a lipotoxic 
concentration of palmitate (500 µM) to model pathophysiological states. Under these 
conditions, wild type (WT) cells were killed, but mutant cells, each with a single 
disrupted gene critical for lipotoxicity, survived. 
This genetic screen led to the identification of many unpredicted genes as 
essential for the lipotoxic response. The eukaryotic elongation factor (eEF) 1A-1 was 
shown to have a role in ROS and ER stress induced death (7). The non-coding RNA 
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gadd7 was shown to be induced by lipotoxic stress in a ROS-dependent fashion and 
drive ROS propagation following palmitate treatment, demonstrating that gadd7 
functions as a feed-forward regulator of lipid-induced and ROS-induced cell death (9). In 
another mutant cell line (6F2), the promoter trap disrupted the locus for ribosomal 
protein L13a (rpL13a) (72). Studies of this mutant revealed that the portions of this gene 
essential for lipotoxicity are three highly conserved small nucleolar RNAs (snoRNAs) 
embedded within the rpL13a introns, rather than the protein-coding exonic sequences. 
These findings suggest a previously unsuspected role for snoRNAs in the regulation of 
metabolic stress in mammalian cells.  
 
Conserved functions of snoRNAs 
SnoRNAs are typically nucleolar-localized RNAs that guide the modification of 
other non-coding RNAs (ncRNAs). Eukaryotic cells contain more than 200 unique 
snoRNAs comprised of two families—the box C/D snoRNAs and box H/ACA snoRNAs 
(57). The vast majority of snoRNAs transiently base pair with complementary target 
RNA to guide either 2’-O-methylation (C/D snoRNAs) or pseudouridylation (H/ACA 
snoRNAs) of target RNA (69). These modifications are the most common covalent 
modifications found in ribosomal RNA (rRNA) and are found in key regions of rRNA 
including the peptidyl transferase center and the mRNA-decoding center. Both types of 
modifications are essential for ribosome function, and the importance of these 
modifications is emphasized by the evolutionary conservation of modification locations. 
Other snoRNA modification targets include snRNAs in eukaryotes, transfer RNAs in 
archaea, and spliced leader RNAs in trypanosomes (16, 19, 111). Spliceosome function 
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also depends on the modification of snRNAs by C/D and H/ACA snoRNAs. Modification 
of snRNAs takes place in Cajal bodies providing evidence for extranucleolar roles for 
snoRNAs (16). The precise function of modified nucleotides in rRNAs and snRNAs 
remains unknown, but they are hypothesized to have a critical function, since complete 
loss of modification causes lethality and specific mutations can cause disease (15). 	  
Both snoRNA families are structurally and functionally conserved from humans to 
Archaea (77, 104, 105). Box C/D snoRNAs contain the conserved sequence motifs 
UGAUGA (C box) and CUGA (D box) near the 5’ and 3’ ends of the snoRNA, 
respectively. The two boxes are separated by ~60nt and internal C’ and D’ boxes are 
often present in that region. Base-pairing to target RNAs typically takes place in the 
region directly upstream of the D box or D’ box, involving a sequence known as the 
antisense element (Figure 1.2) Box C/D snoRNAs are associated with four box C/D 
snoRNP proteins, fibrillarin, Nop56, Nop58, and 15.5K/NHPX (55, 74, 93, 107, 123, 
127). Fibrillarin catalyzes the 2′-O-methyl transfer at the site determined by the box C/D 
snoRNA guide (118) 
 Similarly, H/ACA snoRNAs are characterized by a conserved secondary 
structure. Each H/ACA snoRNA is defined by a hairpin–hinge–hairpin–tail structure with 
two short conserved sequences called boxes H and ACA. One or both hairpins have an 
internal loop with two short sequences that are complementary to the rRNA substrate. 
These pseudouridylation pockets enable anti-sense base-pairing with target RNAs in 
the region where they direct modifications (Figure 1.2). The box H/ACA snoRNAs form 
snoRNP complexes with dyskerin, Nhp2, Nop10, and Gar1 proteins (4, 29, 35, 65, 120). 
The enzyme responsible for uridine-to-pseudouridine isomerization is dyskerin (39). 	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Palmitate treatment induces rpL13a snoRNA accumulation in CHO cells.  
Identification of the snoRNA encoding rpL13a locus through the genetic screen 
conducted in the Schaffer Lab suggested snoRNAs have a role in lipotoxicity. All 
mammalian loci for rpL13a contain four highly conserved intronic box C/D snoRNAs that 
are processed during splicing of the rpL13a pre-mRNA transcript (Figure 1.3A) (75). 
These snoRNAs, U32a, U33, U34, and U35a, are encoded within introns 2, 4, 5 and 6, 
respectively, and range in size from 61-82 nucleotides. U32a, U33, U34, and U35a are 
highly conserved across species.  
 Lipotoxic conditions induce the pre-mRNA expression of many genes including 
rpL13a. Consistent with up-regulation of the pre-mRNA, rpL13a snoRNAs also 
accumulate under stress conditions as assessed by RNase protection assays with 32P-
labeled probes specific for the snoRNA sequences (Figure 1.3B & C). In comparison, 
levels of the microRNA miR-16 do not change under these conditions. In WT CHO cells, 
U32a, U33, and U35a snoRNAs are expressed at low levels under basal conditions and 
increased following palmitate treatment, whereas U34 is not detected under basal or 
lipotoxic conditions. In mutant 6F2 cells, induction of U32a, U33, and U35a is markedly 
attenuated, consistent with disruption of the rpL13a locus (Figure 1.3B & C). Palmitate 
induction of U32a, U33, and U35a snoRNAs is also observed in WT C2C12 murine 
myoblasts, which demonstrate similar sensitivity to lipotoxic conditions (72). Moreover, 
these snoRNAs are induced by saturated fatty acids known to cause lipotoxicity 
(myristic, palmitic, and stearic acids), but not by unsaturated palmitoleic acid and oleic 
acid, which are well tolerated by cells. These findings suggest a conserved role for 
snoRNAs as mediators of lipotoxicity.  
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Confirmation of the role for rpL13a snoRNAs in lipotoxicity. 
Demonstration of rpL13a snoRNAs as mediators of metabolic stress was 
confirmed in two ways (72). First, stable cell lines generated in the mutant 6F2 
background showed that snoRNA sequences within the rpL13a genomic locus are 
required for complementation of 6F2 cells. Mutant cells transfected with a plasmid 
containing 4.3 kb from the murine rpL13a genomic locus, including all eight exons and 
intervening introns, restored palmitate-induced snoRNA expression, palmitate-induced 
ROS, and palmitate-induced cell death. By contrast, when mutant cells were transfected 
with a similar construct in which all four snoRNAs were removed, but promoter and 
exon-intron structure was otherwise intact, complementation was lost. In an alternate 
approach to genetic confirmation, simultaneous knock-down of U32a, U33, and U35a in 
wild-type murine myoblasts by nucleofection with phosphorothioate-modified anti-sense 
oligos (ASOs) rendered these cells resistant to palmitate-induced ROS and cell death. 
Since loss of a single snoRNA alone did not recapitulate lipotoxicity resistance, these 
data support a model in which the three snoRNAs function in concert to promote 
palmitate-induced oxidative stress.  
 
Biogenesis of box C/D and H/ACA snoRNPs  
The ability of the rpL13a locus to regulate oxidative stress is dependent on 
expression of the encoded snoRNAs, which are presumed to form small nucleolar 
ribonucleoproteins (snoRNPs). Biogenesis of box C/D and H/ACA snoRNPs is a highly 
regulated, multi-step process initiated during the transcription of a snoRNA host gene. 
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In vertebrates, the vast majority of box C/D and H/ACA snoRNAs are encoded within 
introns of pre-mRNAs (25, 52, 58, 108, 109). All host introns for vertebrate snoRNAs 
encode only a single intronic snoRNA. During splicing, snoRNAs are excised from the 
pre-mRNA as part of the intron lariat. Mammalian pre-mRNA intron lariats are rapidly 
debranched and degraded after splicing (83). 5’ to 3’ and 3’ to 5’ exonucleases recycle 
the linearized intron lariat (79). Active recruitment of snoRNP proteins to the nascent 
snoRNA during synthesis and/or splicing of the host pre-mRNA is required for efficient 
intronic snoRNP production. The associated snoRNP proteins define the termini of the 
snoRNA by protecting them from the processing exonucleases (13, 51, 108, 122). 
Following trimming of the flanking intron, the mature snoRNP is released. 
Biosynthesis of functional box C/D snoRNPs requires the ordered recruitment of 
snoRNP proteins 15.5K/NHPX, Nop56, Nop58, and fibrillarin. To establish a scaffold for 
the 15.5K/NHPX snoRNP protein, a functional Kink-turn structure must be formed by 
the nascent snoRNA. The 5’ and 3’ box C and D terminal regions of the snoRNA form 
this Kink-turn by folding into a stem-internal loop-stem structure (54, 123). Conserved 
nucleotides in the C and D box motifs form non-canonical G-A, A-G, and U-U base pairs 
establishing the Kink-turn and docking site for the 15.5K/NHPX protein. Binding of 
15.5K/NHPX induces a sharp bend in the phosphodiester backbone of the two 
contiguous RNA stems of the Kink-turn (102, 103, 115, 119). This conformational 
change provides the structural requirements for the subsequent binding of Nop58, 
Nop56, and two copies of fibrillarin (12). One fibrillarin and Nop58 bind to the box D and 
C sequences in the upper stem of the Kink-turn. Nop56 and another copy of fibrillarin 
bind to the internal C’ and D’ boxes. 
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Position within the intron is also critical for efficient processing of human box C/D 
snoRNAs. Most box C/D snoRNAs are located about 80-90 nucleotides upstream of the 
3’ splice site (38). An optimal distance of ~50 nucleotides between the snoRNA coding 
region and the branch point of the host intron is required for efficient snoRNA 
processing. Increasing or decreasing the length between the snoRNA and the branch 
point significantly compromises snoRNA accumulation (37). The relationship between 
snoRNA location and the branch site suggests there is a synergy between intronic 
snoRNA processing and pre-mRNA splicing. Consistent with a splicing-depending 
mechanism for box C/D snoRNA processing, 15.5K/NHPX is recruited to box C/D 
intronic snoRNAs at the C1 splicing complex stage. A general splicing factor, intron 
binding protein 160 (IBP160), provides a molecular link between the spliceosome and 
the nascent box C/D snoRNA (36). IBP160 has putative helicase activity and is thought 
to trigger box C/D snoRNP assembly by interacting with the U2 spliceosomal small 
nuclear RNP (snRNP) or other splicing factors associated with the branch-point region 
in the C1 splicing complex.	  
Box H/ACA snoRNPs also require ordered recruitment of snoRNP proteins. 
However, in contrast to box C/D snoRNAs, human H/ACA snoRNAs have no 
preferential intronic location relative to the 5’ or 3’ splice sites of the host introns (88, 
92). Human box H/ACA snoRNAs are commonly found in introns of longer than average 
length. H/ACA snoRNAs are also processed efficiently from artificial host pre-mRNAs 
regardless of position within the intron suggesting that box H/ACA snoRNAs are 
processed independent of relative splice site location (88).  
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Many class specific factors regulate the biogenesis of box C/D snoRNAs and box 
H/ACA snoRNAs, but the excision of all intronic snoRNPs requires splicing. The 
relationship between pre-mRNA splicing and snoRNA biogenesis suggests the 
spliceosomal machinery is critical for snoRNA expression. The spliceosome is a 
complex RNA machine comprised of its own set of ncRNAs, the small nuclear RNAs 
(snRNAs), and over 100 proteins (117). Each snRNA is bound to a unique set of 
proteins to form a small nuclear ribonucleoprotein (snRNP). In addition to snRNP-
specific proteins, each of the major snRNAs (U1, U2, U4, and U5) is bound to a 
common set of seven proteins (SmB/B’, SmD1, SmD2, SmD3, SmE, SmF, and SmG). 
These proteins form a seven-membered ring around the short, highly conserved, 
uridine-rich sequence on each snRNA called the Sm site (1, 47, 100). Assembly of Sm 
cores onto snRNAs is regulated by the SMN complex (22, 71, 84). Following assembly 
of the Sm protein heptameric ring, the 5’ cap of the snRNA is hypermethylated to form 
the 2,2,7-trimethyl guanosine cap, and the mature snRNP is then imported into the 
nucleus by snurportin and importin β for final association with snRNP-specific proteins 
and utilization in mRNA splicing (23, 24, 42, 70, 86).  
 
Summary 
 Herein, we describe work that provides new understanding of the function of the 
rpL13a snoRNAs in cells and in a rodent model of acute oxidative stress, identifies a 
role for the spliceosomal protein, SmD3, in regulating the biogenesis of intronic ncRNAs 
including the rpL13a snoRNAs, and uncovers a link between superoxide production and 
11 
induction of the rpL13a snoRNAs. Together, our studies provide important new insights 
into the production and function of snoRNAs during metabolic stress. 
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Figure 1.1	  
	  	  
Figure 1.1 Genetic screen to isolate palmitate resistant CHO mutants. Wild type 
(WT) CHO cells were transduced with the ROSAβgeo retrovirus, leading to integration 
of the provirus containing a splice acceptor, promoterless β-galactosidase-neomycin 
resistance cassette, and polyadenylation sequences. Promoter-trapping and gene 
disruption at the site of integration was selected for by growth in neomycin (NEO), and 
palmitate-resistant mutants were selected by growth in media with 500 µM palmitate 
(palm) for 48 h. 
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Figure 1.2 
 
Figure 1.2 Secondary structure of box C/D and box H/ACA snoRNAs. A) Box C/D 
snoRNAs (green) are characterized by box C and D motifs. Sequences upstream of box 
D and D’ base pair (blue) with target RNAs (red) to guide the 2’-O-methylation of target 
RNA. B) Box H/ACA snoRNAs are characterized a hairpin–hinge–hairpin–tail structure 
and box H and ACA motifs. Pseudouridylation pockets allow for base pairing with target 
RNAs to guide pseudouridylation modifications. 
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Figure 1.3 
  
Figure 1.3 rpL13a-encoded box C/D snoRNAs are induced in palmitate treated 
CHO cells. (A)	  rpL13a gene organization showing location of ROSAβgeo promoter trap 
insertion and locations of intronic U32a, U33, U34, and U35a snoRNAs. (B, C) WT and 
6F2 cells were untreated (UT) or supplemented with palmitate for 48 h. (B) Small RNA 
was harvested and used in RNase protection assay with 32P-labeled hamster rpL13a 
snoRNA probes or miR-16 probe as control. (C) Autoradiograms from RNase protection 
experiments as in (B) were quantified by densitometry. All data expressed as mean ± 
SE for 3 independent experiments. * p < 0.01 for palmitate treated vs. untreated.  
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CHAPTER TWO 
rpL13a snoRNAs function as non-canonical box C/D snoRNAs 
 
INTRODUCTION  
 Box C/D snoRNAs U32a, U33, and U35a are critical for the propagation of ROS 
following lipid overload in cultured cells (72). The mechanisms through which rpL13a 
snoRNAs recognize metabolic stress and regulate the cellular stress response remain 
unclear. Typically, box C/D snoRNAs serve as guides for ribonucleoprotein particles 
during 2’-O-methylation of rRNA. These modifications occur within the nucleolus, where 
the vast majority of snoRNAs reside. Extranucleolar functions for snoRNAs have also 
been described. SnoRNAs are known to traffic to Cajal bodies where they can serve to 
guide the modification of snRNAs (16). Recent studies have suggested a number of 
additional non-canonical roles for snoRNAs. A brain specific snoRNA, HBII-52, has 
been shown to interact with a pre-mRNA in the nucleoplasm and play a role in 
alternative splicing (49). Biochemical and computational analyses from multiple groups 
show snoRNAs can be processed into miRNAs in a Dicer dependent fashion, 
suggesting snoRNAs may localize to the cytoplasm where processing and function 
would take place (21, 78, 90). Additional snoRNAs have been identified or 
computationally predicted to lack rRNA or snRNA antisense homology (43). These 
“orphan” snoRNAs could serve as guides for currently unidentified target RNAs in 
unknown locations.  
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 Here, we extend the initial finding that rpL13a snoRNAs are critical mediators of 
metabolic stress by examining their role in vivo. We demonstrate that U32a, U33, and 
U35a contribute to oxidative stress and oxidative damage in a mouse model of 
inflammation and oxidative stress. Furthermore, we broaden our understanding of 
snoRNA function in the metabolic stress pathway in several ways. By examining 
predicted rpL13a modification sites in 6F2 cells, we show that methylation of these 
rRNA nucleotides is not affected by altered levels of the snoRNAs during lipotoxicity. By 
characterizing the localization of rpL13a snoRNAs in wild type cells, we show that they 
accumulate in the cytoplasm during lipotoxicity. This novel localization for intron-
encoded snoRNAs provides insight into the potential mechanism through which rpL13a 
snoRNAs regulate oxidative stress. 
 
RESULTS 
In vivo expression of rpL13a snoRNAs. Our studies of the rpL13a snoRNAs show 
that these molecules function in the cellular response to lipotoxic and oxidative stress. 
To extend these findings to an in vivo model of oxidative stress, we examined the 
expression of rpL13a snoRNAs in a well-established model of lipopolysaccharide (LPS)-
mediated liver injury that is characterized by inflammation, steatosis, and oxidative 
stress (5). Compared to saline-injected control mice, liver tissue from LPS-treated mice 
showed significant up-regulation of cytosolic U32a, U33, and U35a snoRNAs (Figure 
2.1), demonstrating that the rpL13a snoRNAs are induced in vivo in response to 
metabolic stress.  
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In vivo rpL13a snoRNA knockdown reduces oxidative damage. Based on these 
findings, we analyzed the effects of loss-of-function of the rpL13a snoRNAs in the LPS-
mediated liver injury model. To achieve specific knockdown of the snoRNAs in vivo, 
prior to LPS injection, mice were treated with three serial intraperitoneal injections of 
antisense locked nucleic acid oligonucleotides directed against each of the three 
snoRNAs or directed against GFP as a control. Antisense oligonucleotides directed 
against the snoRNAs achieved 72, 84, and 74% knockdown of U32a, U33, and U35a, 
respectively, in liver tissue following LPS injection without diminishing LPS-induced 
inflammation (Figure 2.2). Knockdown of the snoRNAs mitigated LPS-induced oxidative 
stress in the liver as demonstrated by dihydroethidium staining for superoxide and 
oxidative damage to liver tissue proteins and lipids (Figures 2.3 and 2.4). These findings 
indicate that rpL13a snoRNAs are required in vivo for propagation of oxidative stress.  
 
rpL13a guided rRNA modifications are unaltered during lipotoxicity. Canonical box 
C/D snoRNAs participate in ribonucleoproteins that localize to nucleoli. In S. cerevisiae 
and in X. laevis, box C/D snoRNAs serve as guides that target 2’-O-methylation of 
rRNAs with which they share short stretches of antisense homology (53). Although they 
lack some sequence features of canonical 2’-O-methylation guide snoRNAs (internal 
box C’ sequence not well-conserved, U33 lacks box D’, rRNA complementarity not 
upstream of box D in U35a), U32a, U33, and U35a each contain 10-12 nucleotide 
stretches of complementarity to rRNA sites of 2’-O-methylation (Figure 2.5), suggesting 
a potential role as guide RNAs for 2’-O-methylation of G1328 in 18S and A1511 in 28S 
(U32a), U1326 in 18S (U33), and C4506 in 28S (U35a) rRNAs (75). We reasoned that if 
the mechanism of action of snoRNAs U32a, U33, and U35a in lipotoxic and oxidative 
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stress involved 2’-O-methylation of these rRNAs, modifications of these rRNA sites 
should be diminished in 6F2 compared to WT cells under metabolic stress conditions 
when the snoRNAs are induced in WT cells. However, primer extension studies showed 
no differences in the extent of modification of these rRNA sites between WT and 6F2 
cells under basal or palmitate-treated conditions (Figure 2.6). These data indicate that 
under basal and lipotoxic conditions, either residual expression of U32a, U33, and U35a 
in 6F2 cells is sufficient to support these modifications of rRNAs, or this function is 
subserved by other molecules in eukaryotic cells. Furthermore, at a point in the lipotoxic 
response at which absence of snoRNA induction is readily apparent and functionally 
correlates with resistance to lipotoxicity in 6F2 cells, there is no corresponding change 
in 2’-O-methylation of rRNAs.  
 
rpL13a snoRNAs accumulate in the cytoplasm during lipotoxicity. We 
hypothesized that if U32a, U33, and U35a were involved in functions other than 
modification of ribosomal RNAs, then under lipotoxic stress conditions, they may have a 
subcellular distribution distinct from canonical box C/D snoRNAs, which co-localize with 
nascent rRNAs in the nucleolus. Following palmitate treatment of C2C12 cells, we 
isolated nuclear and cytosolic RNAs by sequential detergent extraction and quantified 
U32a, U33, and U35a by qRT-PCR. With palmitate treatment U32a, U33, and U35a 
increase in the cytoplasm, whereas levels of these snoRNAs remain unchanged in the 
nucleus (Figure 2.7A and B). Accumulation of rpL13a snoRNAs in the cytosol under 
lipotoxic conditions was confirmed by fluorescence in situ hybridization. As expected, 
anti-sense probe for snoRNA U3 demonstrated strong nucleolar localization, and this 
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was unaffected by lipotoxic stress (Figure 2.8A). Staining for the rpL13a snoRNAs was 
performed in cells nucleofected with control ASO (GFP) or with ASO targeting each of 
the rpL13a snoRNAs to ascertain the specificity of signal. Consistent with data from 
RNase protection and qPCR assays, in control nucleofected cells expression of U32a, 
U33, and U35a was low under normal growth conditions and increased under lipotoxic 
conditions (Figure 2.8B, GFP-nucleofected panels). Prominent staining for each of 
these snoRNAs was observed in the cytoplasm, but not nucleoli. The probe for U32a 
also stains non-nucleolar regions of the nucleus. Cytoplasmic staining for the rpL13a 
snoRNAs under lipotoxic conditions was markedly diminished when the snoRNAs were 
depleted by specific ASOs that target each snoRNA (Figure 2.8B, U32a, U33, and U35a 
ASO-nucleofected panels). Cytoplasmic staining for U32a, U33, and U35a was also 
distinct from the nuclear pattern observed under lipotoxic conditions using a probe 
specific for intron 1 (Figure 2.8A), indicating that the cytosolic distributions of the rpL13a 
snoRNAs do not simply reflect localization of the pre-mRNA. The nuclear staining for 
U32a resembled the staining for intron 1 and was not diminished with ASOs that target 
U32a, suggesting that this represents detection of the pre-mRNA, which is not targeted 
by U32a ASOs. Together our biochemical and in situ hybridization data support a model 
in which U32a, U33, and U35a snoRNAs act in non-canonical roles in the cytoplasm 
during lipotoxic stress.  
 
CONCLUSIONS 
SnoRNAs U32a, U33, and U35a are critical for the cellular response to metabolic 
stress. In vivo knockdown of these three snoRNAs further illustrates their importance to 
the pathophysiology of metabolic stress. The LPS-induced model of hepatic tissue injury 
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confirms that the rpL13a snoRNAs are induced in the setting of oxidative stress in vivo. 
Moreover, our in vivo knockdown data show that these snoRNAs are required for 
amplification of oxidative stress and for propagation of oxidative stress-mediated 
damage to proteins and lipids. Because LPS has pleiotropic effects in vivo and because 
ASO knockdown in vivo is limited by liver toxicity, it is not surprising that in vivo 
knockdown of these snoRNAs provided only a partial reduction in the oxidative stress 
response and did not blunt the release of serum transaminases into the circulation (not 
shown). In future studies, genetic approaches to loss of function and/or blunting of 
additional effector pathways (e.g., inflammatory signaling) may be required to block liver 
injury entirely. Nonetheless, our in vivo knockdown studies show that the rpL13a 
snoRNAs are required for the full induction of tissue oxidative stress in the murine LPS 
model, thus providing in vivo evidence for a role of snoRNAs in metabolic stress.  
We show here in a stable mutant cell line that decreased basal expression of 
U32a, U33, and U35a snoRNAs and loss of palmitate induction of these snoRNAs is not 
associated with changes in 2’-O-methylation of predicted rRNA targets, yet is 
associated with resistance to lipotoxicity. While it is possible that these snoRNAs 
contain more than one functional guide sequence to target multiple substrates including 
rRNAs (13, 110), their accumulation in the cytosol during lipotoxicity suggests a non-
nucleolar function for these snoRNAs. Movement of snoRNAs to the cytosol is not 
without precedent, since the independently transcribed box C/D snoRNA, U8, has been 
shown to be exported from the nucleus (121). Here, we provide the first direct evidence 
that intronic snoRNAs can also localize to the cytosol. Our data are most consistent with 
a model in which the rpL13a snoRNAs function in lipotoxicity and oxidative stress 
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response pathways as non-canonical box C/D snoRNAs. Furthermore our findings 
suggest that the rpL13a snoRNAs affect targets in the cytoplasm.   
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Figure 2.1 
 
Figure 2.1 In vivo expression of rpL13a snoRNAs. (A) Mice were injected 
intraperitoneally with lipopolysaccharide (LPS), or equivalent volume of phosphate-
buffered saline (PBS) as control, and liver tissue was harvested 12 h later. Cytosolic 
RNA isolated from livers was used for quantification of rpL13a snoRNAs (relative to 
36B4) or iNOS and Cox2 (relative to actin). Graph shows mean ± SE from a 
representative experiment with N = 3 (PBS) and N = 4 (LPS) animals per group. * p < 
0.05 for LPS vs. PBS.  
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Figure 2.2 
 
Figure 2.2 ASO knockdown of rpL13a snoRNAs in vivo. Mice were pretreated with 
three serial doses of ASOs targeting rpL13a snoRNAs or GFP as control prior to LPS 
injection and analysis of liver tissue. snoRNA, iNOS, and Cox2 expression in liver 
cytosol was quantified as in Figure 2.3. n = 4 to 6 per group. 
* p < 0.05 for GFP vs. snoRNA knockdown. 
  
U32a U33 U35a 
0.0
0.5
1.0
1.5
ta
rg
et
:c
on
tro
l R
N
A
(re
l u
ni
ts
)
gfpLNA + LPS
snoLNA + LPS
* * *
0.0
0.5
1.0
1.5
iNOS
0.0
0.5
1.0
1.5
2.0
Cox2
*
24 
Figure 2.3 
 
 
Figure 2.3 rpL13a snoRNAs are required for oxidative stress in vivo. Mice were 
pretreated with three serial doses of ASOs targeting rpL13a snoRNAs or GFP as control 
prior to LPS injection and analysis of liver tissue. Representative images show frozen 
sections of liver tissue stained with DHE and parallel sections in which staining was 
performed in the presence of pegylated superoxide dismutase (SOD) as control. Scale 
bar, 100 µm. Graph shows quantification of fluorescence intensity. n = 4 to 6 per group. 
* p < 0.05 for GFP vs. snoRNA knockdown.  
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Figure 2.4 
 
 
Figure 2.4 In vivo rpL13a snoRNA knockdown reduces oxidative damage. Mice 
were pretreated with three serial doses of ASOs targeting rpL13a snoRNAs or GFP as 
control prior to LPS injection and analysis of liver tissue. Quantification of (A) protein 
carbonylation by western blotting and (B) tissue oxysterols (7-ketocholesterol, 7-keto; 
3β,5α,6β-cholestantriol, triol) 24 h following LPS. n = 4 to 6 per group. * p < 0.05 for 
GFP vs. snoRNA knockdown. 
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Figure 2.5 
 
Figure 2.5 U32a, U33, and U35a contain antisense homology to rRNA. Comparison 
of rpL13a snoRNA sequences from mouse (Mm), hamster (Cg), and human (Hs) 
species. C, D, and D’ box sequences are indicated in boxed bolded text. Regions with 
antisense homology are underlined. Conserved and non-conserved nucleotides are 
displayed in lower and upper case letters, respectively. 
U32a
 
Mm GAgtcCAtgatgagcaacaCtcaccatctttcgtttgagtctcacgAcTGtgagatcaa-cccatgcaccgctctgagacTC
Cg AAgtcAGtgatgagcaacaAtcaccatctttcgtttgagtctcacgAcTGtgagatcaa-cccatgcaccgctctgagacTT
Hs AGgtcAGtgatgagcaacaTtcaccatctttcgtttgagtctcacgGcCAtgagatcaaCcccatgcaccgctctgagacCT
U33
 
Mm cAgcTTGtgatgagA-c-AtctcccactCATGttcgagttGcTcGacTatgagaTGactcTacatgcactaccatctgaggcTGT
Cg cAgcCTAtgatgaAG-cGAtctcccactGGTGttcgagttTcCcAacTatgagaCAactcTacatgcactaccatctgaggcTGG
Hs cGgcCGGtgatgagAAc-TtctcccactCACAttcgagttTcCcGacCatgagaTGactcCacatgcactaccatctgaggcCAC
U34
 
Mm cgtcTGtgatgttcTgcTaTtacctacattgtttgaGcctcatgaaaAcCCcactGgctgagacgc
Cg cgtcTGtgatgttcTgcTaTtacctacattgtttgaGcctcatgaaaAcGCcactAgctgagacgc
Hs cgtcCAtgatgttcCgcAaCtacctacattgtttgaTcctcatgaaaGcAGcactGgctgagacgc
U35a
 
Mm ggcaCatgatgtTCttatTctcacgatggtctTcggatgCcAcAgTTAGgGCaGtgCcgaTaatgccaAAggctAagctgatgccagGa  
Cg ggcaGatgatgtTTttTtTctcacgatggtctTcggatgCcAcCgATTGg-CaGtgCcgaTaatgccaCAggctCagctgatgccagTa
Hs ggcaGatgatgtCCttat-ctcacgatggtctGcggatgTcCcTgT---gGGaAtgGcgaCaatgccaATggctTagctgatgccagGa
From Michel et al. 2011
box C box D' box D
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 Figure 2.6 
 
Figure 2.6 2’-O-methylation is unaffected in 6F2 cells. WT and 6F2 cells were 
treated with 500 µM palmitate and total RNA analyzed for pseudouridylation or 2’-O-
methylation nucleotide modification of predicted sites using reverse transcriptase primer 
extension. Autoradiograms show primer extension assays and parallel sequencing for 
detection of (A) U32a and U33 target sites on 18S rRNA (G1328 and U1326, 
respectively); (B) U32a target site on 28S rRNA (A1511); (C) U35a target site on 28S 
rRNA (C5406); (D) unrelated snoRNA target sites on 18S rRNA as controls (snoRNAs 
Z17a & Z17b target U121; snoRNAs U45a & U45c target A159). For each panel, arrows 
point to bases in rRNA (numbered according to human rRNA sequence) that are 
modified and corresponding DNA sequence is shown in the left-most four lanes. 
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Figure 2.7 
 
Figure 2.7 rpL13a snoRNAs accumulate in the cytoplasm under lipotoxic 
conditions. (A, B) C2C12 cells were untreated (UT) or treated with palmitate for 24 h. 
Cells were separated into cytosolic (CYT) and nuclear (NUC) fractions by sequential 
detergent solubilization. (A) Fractions were analyzed by western blotting for a cytosolic 
marker, hsp90, and for a nuclear marker, lamin B1. (B) Total RNA was prepared from 
the fractions and analyzed for rpL13a snoRNA abundance relative to 36B4 by qRT-
PCR. Graphs show mean ± SE from a representative experiment (n = 3). * p < 0.05 for 
palmitate treated vs. UT.   
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Figure 2.8 
 
Figure 2.8 rpL13a snoRNAs accumulate in the cytoplasm under lipotoxic 
conditions. (A, B) C2C12 cells were analyzed by in situ hybridization under basal 
conditions (UT) and following 24 h treatment with palmitate (PALM) using specific 
snoRNA or control probes (red). Nuclei were stained with SYTOX Green. (A) Cells were 
probed with U3 antisense probe for known nucleolar snoRNA, control U3 sense probe, 
and control rpL13a intron 1 antisense probe. (B) Control GFP ASO-nucleofected and 
specific snoRNA ASO-nucleofected cells were examined by in situ hybridization with 
antisense probes for U32a, U33, and U35a. Bars, 10 µm.   
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CHAPTER THREE 
SmD3 regulates intronic snoRNA biogenesis 
 
INTRODUCTION 
Most vertebrate snoRNAs are encoded within introns and co-transcribed with 
their host genes (109). Intronic box C/D snoRNP protein assembly initiates during the 
C1 complex stage of splicing (37), with subsequent intron lariat formation at the C2 
complex stage of splicing followed by debranching and exonucleolytic trimming of the 
mature snoRNP (51, 80, 85). The observations that rpL13a snoRNAs rapidly 
accumulate in the cytosol during metabolic stress and are required for lipotoxic cell 
death suggest that cytoplasmic RNAs may be their primary targets and that efficient 
processing of these intronic elements is important for the lipotoxic response. However, 
the precise molecular mechanisms through which snoRNAs are induced and regulated 
during lipotoxicity remain to be elucidated. 
 Our genetic screen led to isolation of a second, independent mutant cell line 
harboring a disruption in an RNA-related gene. This novel mutant cell line is 
haploinsufficient for SmD3, a core component of the spliceosome. We demonstrate that 
SmD3 participates in the lipotoxic response through regulation of intron lariat 
abundance and biogenesis of intron-encoded rpL13a snoRNAs. We also provide 
evidence linking the expression of SmD3 to the levels of critical snRNA components of 
the spliceosome and generalized production of intronic non-coding RNAs (ncRNAs). 
Our results extend the known function for SmD3 in splicing to a specific role within 
individual snRNPs essential for the biogenesis of intronic ncRNAs.  
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RESULTS 
SmD3 haploinsufficiency confers resistance to palmitate-induced cell death. The 
6H2 mutant cell line was isolated from our genetic screen for genes that are critical for 
the lipotoxic response. To quantify the degree of palmitate resistance in mutant 6H2, 
WT and 6H2 cells were treated with palmitate for 48 h, and cell death was quantified by 
propidium iodide (PI) staining and flow cytometric analysis. Compared to WT cells, 6H2 
cells were significantly protected from palmitate-induced death (Figure 3.1A). By 
contrast, treatment of WT and 6H2 cells with the general apoptosis inducers 
camptothecin, staurosporine, and actinomycin D revealed no differences in sensitivity. 
Therefore, palmitate-resistant 6H2 cells are not generally resistant to cell death.  
The promoter trap mutagenesis facilitated identification of the disrupted gene 
because of the unique fusion transcript produced upon a single productive integration. 
To confirm the presence of a single retroviral integration, Southern blot analysis of 6H2 
genomic DNA was performed, probing for the ROSAβgeo sequence (Figure 3.2A). The 
presence of a single hybridizing band in DNA digested with multiple different restriction 
enzymes is consistent with a single retroviral integration. To identify the disrupted gene 
in the mutant 6H2 cells, mRNA was isolated and used for 5’ rapid amplification of cDNA 
ends (5’ RACE). Unique sequence from the RACE product was analyzed using NCBI 
BLAST, which revealed that the site of integration was the snrpD3 gene encoding the 
small nuclear ribonucleoprotein SmD3. SmD3 is a component of the spliceosome that, 
together with other Sm family proteins, forms a heteroheptameric ring around snRNAs 
U1, U2, U4, and U5 to generate small nuclear ribonucleoproteins (snRNPs) essential for 
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the removal of introns from pre-mRNA (125). PCR was performed to confirm integration 
of the ROSAβgeo sequence into snrpD3 (Figure 3.2B). Reactions with forward and 
reverse primers designed to snrpD3 resulted in PCR products for both WT and 6H2 
cDNA, indicating that each cell type maintains at least one intact allele. As expected, no 
product was detectable in WT cells when snrpD3 forward and ROSAβgeo reverse 
primers were used, but this set of primers produced the expected PCR product from the 
fusion transcript in 6H2 cells. These PCR results confirm our 5’ RACE identification of 
the disrupted gene and suggest that 6H2 cells are haploinsufficient for snrpD3. 
Consistent with this model, quantitative real-time PCR (qRT-PCR) revealed a ~50% 
reduction in relative snrpD3 mRNA (Figure 3.2C) and western blotting revealed a 
corresponding ~50% reduction of SmD3 protein (doublet at 15 kDa and 18 kDa) in 6H2 
relative to WT cells (Figure 3.2D). Thus, expression of snrpD3 in 6H2 cells is consistent 
with a model in which integration of the ROSAβgeo provirus disrupted one of two alleles 
for snrpD3. 
 
Targeted knockdown of SmD3 recapitulates 6H2 phenotype. To confirm that the 
palmitate-resistant phenotype in 6H2 cells is due to diminished SmD3 protein 
expression, we used shRNA to knockdown SmD3 in WT CHO cells and tested for 
associated changes in palmitate sensitivity. SmD3 protein levels were measured by 
western blot following isolation of individual stable clonal knockdown lines. Two 
independently isolated clonal lines showed 47% (sh1) and 64% (sh2) knockdown 
relative to scrambled (contr) shRNA transfected cells (Figure 3.3A and 3.3B). 
Knockdown clones were protected from palmitate-induced death as measured by PI 
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staining, and the degree of protection was proportional to the degree of knockdown 
(Figure 3.3C). These data provide independent genetic evidence that loss-of-function of 
SmD3 protects against lipotoxicity.  
 
SmD3 disruption protects cells from generalized oxidative stress induction. 
Lipotoxicity is known to involve fatty acid (FA) import and the generation of oxidative 
stress (8, 60). To test whether 6H2 cells acquired resistance through diminished 
capacity to take up palmitate, initial rates of FA uptake were quantified in WT and 6H2 
cells. There was no significant difference between WT and 6H2 cells (Figure 3.4A), 
indicating that resistance to lipotoxicity in 6H2 cells did not result from failure to take up 
exogenous FA. To probe downstream aspects of the lipotoxic response, we quantified 
palmitate-induced ROS in WT and 6H2 cells by CM-H2DCFDA (DCF) staining and flow 
cytometric analysis. At 5 and 16 h following palmitate supplementation, ROS induction 
was significantly blunted in 6H2 cells (Figure 3.4B). SmD3 knockdown clones were also 
protected from palmitate-induced ROS (Figure 3.4C). More direct induction of oxidative 
stress following exposure to H2O2 or menadione also resulted in blunted ROS levels in 
6H2 cells compared to WT (Figure 3.4D), indicating 6H2 cells are protected not only 
from palmitate-induced ROS but also from generalized oxidative stress induction or 
amplification. 
 
SmD3 regulates intronic non-coding RNA expression. The ROS resistance 
phenotype observed in 6H2 cells is similar to the previously described 6F2 mutant. 
Given the related phenotypes of these two mutants, and the well-appreciated 
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interactions of SmD3 with RNA, we assayed for the expression of the rpL13a snoRNAs 
in 6H2 cells by RNase protection assay. Following palmitate treatment, WT cells show 
the expected increase in snoRNA expression by RNase protection (Figure 3.5A). Under 
the same conditions, snoRNA induction is blunted in 6H2 cells. Similarly, SmD3 
knockdown clones were impaired in rpL13a snoRNA induction relative to control (Figure 
3.5B). While snoRNAs are thought to be produced in the nucleus and canonical box 
C/D snoRNAs function in that location, our data demonstrates that rpL13a snoRNAs 
accumulate in the cytosol during metabolic stress (Chapter 2). Fractionation of WT and 
6H2 cells by sequential detergent solubilization revealed that under basal conditions 
snoRNAs are detectable in the nucleus and the cytosol but are substantially more 
abundant in the nucleus (Figures 3.5C and 3.5D). qRT-PCR analysis of these fractions 
reveals reduced rpL13a snoRNAs in the cytosol in 6H2 cells under palmitate-treated 
conditions, and reduced levels of these snoRNAs in the nucleus under both basal and 
palmitate-treated conditions (Figures 3.5E and 3.5F). The observation that 
haploinsufficiency of SmD3 caused impairment of basal expression and lipotoxic 
cytosolic accumulation of the intronic rpL13a snoRNAs, a deficit known to cause 
resistance to lipotoxicity, is consistent with the ROS resistant phenotype observed in 
6H2 cells. Furthermore, the observation that nuclear levels of the rpL13a snoRNAs are 
decreased in 6H2 cells under basal as well as lipotoxic conditions implicates a defect in 
the nuclear production of the snoRNAs.  
To test whether 6H2 cells have a general defect in expression of intronic 
snoRNAs, we measured basal nuclear expression of intronic box C/D snoRNAs U50, 
U57, U60, and U21 and intronic box H/ACA snoRNAs U17b, U64, and ACA28 (Figure 
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3.5G). Expression of each of these snoRNAs was reduced in the nuclei of 6H2 versus 
WT cells. Furthermore, we measured the expression of intronic splicing-
dependent/Drosha-independent pre-miRNAs to probe an unrelated class of intronic 
ncRNAs (6, 89). Mirtrons miR-1224 and miR-1225 showed reduced expression in 6H2 
cells. In contrast, independently transcribed, splicing-independent, non-intronic 
snoRNAs U8 and U13 and pre-miR-23a showed no difference in expression between 
WT and 6H2. Taken together, these data suggest that WT levels of SmD3 are generally 
required for effective expression of splicing-dependent intronic ncRNAs.  
 
SmD3 knockdown perturbs snRNP biogenesis. Disruption of multiple components of 
the snRNP assembly pathway has previously been shown to alter snRNP expression 
(98, 130). To test whether reduced levels of SmD3 affect snRNA expression, we used a 
chimeric locked nucleic acid/DNA (LNA/DNA) oligonucleotide to specifically knockdown 
SmD3 in murine fibroblasts. Following knockdown of SmD3 to ~50% of control SmD3 
levels, we observed reductions in rpL13a snoRNAs similar to our mutant, (Figures 3.6A 
and 3.6B).  In SmD3 knockdown cells, qRT-PCR revealed that U4 and U5 snRNA 
expression was decreased, but levels of other snRNAs were indistinguishable from 
control (Figure 3.6C). Since unbound snRNAs are unstable compared to snRNAs in 
snRNP complexes, quantification of snRNA levels provides insight into snRNP integrity 
(91, 131). Consistent with this, U4 and U5 snRNAs were reduced following 
immunoprecipitation with the α-Sm protein Y12 antibody, indicating that U4 and U5 
snRNPs are also diminished (Figure 3.6D). By contrast, 50% knockdown of SmB, 
another Sm protein family member, produced more modest decreases in snoRNA 
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production (Figure 3.6F). SmB knockdown cells remained sensitive to palmitate-induced 
death (Figure 3.6G) and displayed a different pattern of alteration of snRNA expression, 
characterized by decreases in U2 and U4 and increase in U4atac (Figure 3.6H). Our 
data suggest that a reduction in SmD3 expression disrupts a specific set of snRNPs. 
While there is some overlap with the effects of SmB knockdown on snRNA levels, the 
pattern with SmD3 is distinct.  
 
6H2 cells display normal splicing efficiency. Given that SmD3 levels affect snRNP 
expression, we hypothesized that differences in intronic ncRNA expression caused by 
SmD3 haploinsufficiency in the 6H2 cells could be explained by a defect in splicing. To 
assess splicing related to the rpL13a snoRNAs, we measured the expression of 
endogenous rpL13a splicing precursors and spliced products. There was no difference 
in rpL13a pre-mRNA levels between WT and 6H2 cells under basal or palmitate-treated 
conditions, as assessed by amplifying random hexamer-primed cDNA with primer pairs 
designed across the junction between exon 3 and intron 3 (Ex3/Int3, Figures 3.7A and 
3.7B). Quantification of the endogenous rpL13a mRNA, using oligo-dT-primed cDNA 
and primers designed across the splice junction between exons 7 and 8, showed similar 
expression between WT and 6H2 cells (Ex7/8, Figures 3.7A and 3.7B). Furthermore, 
priming across four splice junctions formed by the removal of snoRNA-encoding introns 
(Ex 2/3, 4/5, 5/6, and 6/7) displayed similar expression between WT and 6H2 cells 
(Figures 3.7A and 3.7B).  
To assess splicing efficiency more broadly, we transfected WT and 6H2 cells 
with a previously validated reporter construct for expression of firefly luciferase from two 
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exons separated by a β-globin intron (128). Functional splicing results in the formation 
of a luciferase mRNA encoding a protein with measurable luminescence and a 
processed β-globin intron lariat. In the absence of splicing, a truncated luciferase protein 
without enzymatic activity is formed due to multiple in-frame stop codons. Following 
transfection of this construct, no difference in luciferase production was detected 
between WT and 6H2 under untreated or palmitate treated conditions or in the presence 
of clotrimazole, a known splicing inhibitor (128) (Figure 3.7C). To test whether the 
presence of an intronic snoRNA affected splicing of flanking exons in 6H2 cells, we 
replaced the intron in the split luciferase vector with the murine rpL13a intron 2 
containing U32a. Following transfection with this construct, there was no difference in 
luciferase levels between WT and 6H2 cells, although expression of the exogenous 
murine U32a was reduced in 6H2 cells (Figures 3.7D and 3.7E). Similarly, we detected 
no difference in luminescence using a Δsno split luciferase splicing reporter containing 
mutated rpL13a intron 2 sequences lacking the entire 83 nucleotide U32a, and pre-
mRNA from the reporters with the intact U32a intron and the Δsno intron were 
comparable (not shown). Furthermore, we quantified mRNA expression of the host 
genes containing the intronic non-coding elements quantified in Figure 3.5G. We 
detected no differences in mRNA levels from any of these host genes between WT and 
6H2 cells (Figure 3.7F). Together, these data indicate that differences in intronic non-
coding RNA levels are not attributable to defective splicing of exons in 6H2 cells. 
 
SmD3 knockdown does not alter alternative splicing. Previously, it was reported 
that 85% or more knockdown of the survival of motor neuron (SMN) protein disrupts the 
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snRNP assembly pathway and leads to widespread differences in snRNA levels and 
alternative splicing in a number of tissues (130). To test whether reduced levels of 
SmD3 affected snoRNA processing through broad alterations in alternative splicing, 
exon utilization in control (GFP) and SmD3 knockdown cells was analyzed using the 
Affymetrix GeneChip mouse exon 1.0 ST microarray. Due to the lack of publically 
available exon microarrays containing hamster sequences, we used our LNA/DNA 
oligonucleotides to generate murine fibroblasts with haploinsufficiency of SmD3 to 
phenocopy the 6H2 cells that have 50% wild type CHO levels for this protein (Figures 
3.6A and 3.6B). Following knockdown, RNA was harvested from three independent 
samples of GFP and SmD3 knockdown cells. Among the 266,200 probesets supported 
by putative full-length mRNA, ∼190,000 probesets with significant signals above 
background and representing exons of ~16,000 out of ~30,000 genes in the mouse 
genome were included in the analysis. With a false discovery rate set at less than 0.1, 
no genes were identified as having potential splicing pattern changes (fold change ≥ 
1.5). Plotting probeset intensity values from control (GFP LNA) samples against SmD3 
knockdown samples revealed a highly linear relationship (R2 = 0.98475), consistent with 
little variance between the two groups (Figure 3.8). These data show that a 50% 
reduction in SmD3 expression does not have global effects on alternative splicing. 
 
SmD3 controls intron lariat abundance. Box C/D snoRNAs, box H/ACA snoRNAs, 
and mirtrons are each defined by unique consensus sequences, protein assembly 
factors, and position within the intron (6, 38, 69, 88, 89). Nonetheless, these intronic 
non-coding RNAs all require pre-mRNA splicing, intron lariat formation, debranching, 
39 
and exonucleolytic trimming prior to formation of a functional ribonucleoprotein. We 
used qRT-PCR to probe snoRNA precursors to determine the level of processing at 
which 6H2 cells are defective. Intron lariats from each rpL13a snoRNA-containing intron 
were quantified by qPCR primers reading across the branch point with a sense primer 
designed to a 3’ region of the intron and an antisense primer to a 5’ region (116). This 
approach revealed a 38-63% decrease in lariats from each of the snoRNA-containing 
rpL13a introns under untreated and palmitate treated conditions in 6H2 cells (Figure 
3.9A). Validity of this approach was confirmed by the observation of a single PCR 
product for each intron lariat (Figure 3.9B) and sequence analysis of the PCR products 
(Figure 3.9C). Each primer pair read across the branch point and allowed for mapping 
branch sites in rpL13a introns, each defined by an adenosine and 6 of 7 nucleotides 
correlating with the consensus major spliceosome branch site. Interestingly, we were 
unable to detect PCR products for endogenous rpL13a intron lariats lacking snoRNAs, a 
finding consistent with recent work from others showing that intronic sequences lacking 
snoRNAs are degraded more quickly than introns containing snoRNAs (126).  On the 
other hand, we were able to quantify both snoRNA-containing and non-snoRNA-
containing introns when they were overexpressed in cells transfected with the split 
luciferase vector construct containing the U32a intron and the snoRNA-deleted U32a 
sequence, respectively. In WT cells the presence of the intronic snoRNA was 
associated with increased lariat abundance, whereas this apparent increase was not 
observed in 6H2 cells (Figure 3.9D). These findings suggest that SmD3 contributes to 
expression of intronic snoRNAs by enhancing intron lariat formation or stability.  
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CONCLUSIONS 
Through the use of a genetic screen in CHO cells, our laboratory has identified 
loci involved in lipid-induced cell death, a process in which oxidative stress is a central 
feature. Lipotoxic and oxidative stress critically involve cytosolic expression of intronic 
snoRNAs from the rpL13a genomic locus (72). We provide additional insight into the 
underlying mechanisms of metabolic stress responses through the characterization of a 
mutant cell line with disruption of one allele of the gene encoding SmD3. Our data show 
that reduced cellular levels of SmD3 decrease the propagation of oxidative stress and 
protect cells from palmitate-induced death. Although mutant 6H2 cells are distinct from 
previously described palmitate-resistant mutants from our screen, mutation at the SmD3 
locus confers a related molecular phenotype in that 6H2 cells fail to induce rpL13a 
snoRNAs under lipotoxic stress. We show that SmD3, beyond its known role in splicing, 
regulates expression of the intronic snoRNAs. Compared to WT levels of SmD3, 
reduced levels of SmD3 lead to decreased intron lariat abundance and decreases in U4 
and U5 snRNPs necessary for intron lariat formation. These perturbations decrease the 
basal levels of the rpL13a intronic snoRNAs and subsequently blunt their induction 
during lipotoxicity.  
SmD3 together with six other Sm proteins form a heptameric ring around the 
uridine-rich Sm-binding site found in snRNAs. These snRNPs form the major building 
blocks of the spliceosome. Sequential assembly of the hetero-oligomers of SmD1-D2, 
SmE-F-G, and SmB/B’-D3 is a highly regulated process (27, 84). Although these 
proteins are critical for proper snRNP assembly, our data indicate that 
haploinsufficiency of SmD3 is sufficient to maintain splicing of a specific endogenous 
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pre-mRNA and an exogenously provided splicing reporter under normal growth 
conditions. Consistent with an ability to support overall wild type capacity for mRNA 
splicing, the growth of mutant 6H2 cells is indistinguishable from parental wild type cells. 
These findings suggest that excision of introns during the catalytic stage of splicing 
goes to completion and haploinsufficient levels of SmD3 in these cells is not limiting for 
production of mRNAs. Furthermore, ~50% knockdown of SmD3 does not cause global 
changes in exon utilization. These findings indicate that the phenotype of SmD3 
haploinsufficiency does not relate to global defects in formation of mRNAs. 
To our knowledge, this is the first report of the loss-of-function phenotype for 
SmD3. The finding of a second mutation that reduces rpL13a snoRNA expression and 
leads to resistance to lipotoxicity further highlights the important role of these ncRNAs in 
metabolic stress responses. More importantly, our study provides novel insights into the 
broader molecular cell biology of intronic non-coding RNA elements. Future studies of 
the precise molecular interactions of SmD3 within individual snRNPs are likely to 
elucidate mechanisms through which this protein regulates non-coding RNA biogenesis. 
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Figure 3.1 
 
Figure 3.1 6H2 cells are resistant to palmitate-induced cell death. (A) WT and palm-
resistant 6H2 mutant cells were incubated with 500 µM palm for 48 h; or 10 µM 
camptothecin (camp), 80 nM staurosporine (staur), or 2 µM actinomycin D (actD) for 24 
h. Cell death was quantified by propidium iodide (PI) staining and flow cytometry. Data 
are expressed as mean fluorescence ± standard error (SE) for 3 independent 
experiments with 104 cells/sample. *, p<0.005 for 6H2 versus WT. 
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Figure 3.2 
 
Figure 3.2 6H2 cells are haploinsufficient for SmD3. (A) Autoradiogram shows 
Southern blot analysis of WT (lanes 1-3) and 6H2 (lanes 4-6) genomic DNA digested 
with restriction enzymes Bgl II, NcoI, or XbaI. Blot was probed with a 32P-labeled 
fragment corresponding to the ROSAβgeo sequence. (B) PCR was performed on cDNA 
from WT (lanes 1 and 2) and 6H2 (lanes 3 and 4) cells with reactions containing no 
cDNA as controls (lanes 5 and 6). Forward (F) and reverse (R) primers for snrpD3 were 
designed to detect endogenous snrpD3 (lanes 1, 3, and 5). Forward snrpD3 primer and 
reverse primer for the proviral sequence were used to detect fusion transcript (lanes 2, 
4, and 6). (C) RNA was isolated from WT and 6H2 cells and reverse transcribed using 
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either random hexamers (ran hex) to prime total RNA or oligo dT to prime mRNA. 
snrpD3 expression was determined by quantitative real-time PCR (qPCR) and 
normalized to β-actin expression. (D) Protein expression in WT and 6H2 cells was 
determined by western blotting and quantified by densitometry. Bands at 15 kDa and 18 
kDa likely reflect known post-translational modification of SmD3. Representative blot 
shown for SmD3 and β-actin control. On bar graphs, data are expressed as mean ± SE 
for three independent experiments. *, p < 0.05 for 6H2 versus WT. 
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Figure 3.3 
 
Figure 3.3 Targeted knockdown of SmD3 confers palmitate-resistance. Stable 
clonal cell lines were generated following transfection with a scrambled (contr) or 
snrpD3-targeting shRNA (sh1 and sh2). (A) SmD3 and β-actin protein expression was 
determined by western blot. Blot shows three independent protein samples from each 
respective cell line. (B) SmD3 expression relative to β-actin was quantified by 
densitometry of blots as shown in A. Graph shows mean ± SE for three independent 
samples. *, p < 0.05 for knockdown versus scrambled. (C) Scrambled and knockdown 
cells were treated with palm for 48 h and cell death was assessed by PI staining and 
flow cytometry. All data are expressed as mean fluorescence ± SE for three 
independent experiments with 104 cells/sample. *, p<0.005 for knockdown versus 
scrambled.  
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Figure 3.4 
 
Figure 3.4 SmD3 disruption protects cells from palmitate-induced and generalized 
oxidative stress induction. (A) WT and 6H2 cells were incubated with 14C-palmitate 
under lipotoxic conditions (500 µM palm). Mean initial rates of palmitate uptake are 
expressed per µg protein (± SE) for 3 independent experiments. (B,C,D) WT and 6H2 
cells were incubated with palmitate (B, 5 hr and 16 h), scrambled (contr) and 
knockdown (sh1 and sh2) cells were treated with palmitate (C, 16 h), or WT and 6H2 
cells were untreated (UT) or treated with menadione (mena) or H2O2 (D, 2h). ROS 
induction was assessed by CM-H2DCFDA (DCF) labeling and flow cytometry. Graphs 
show mean fluorescence ± SE for 3 independent experiments with 104 cells/sample. *, 
$#(& ' '



	 
%!"


!)
$&
'

#

&
!)
#
('

 
 


   





 
%!"
 


!)
$&
'

#

&
!)
#
('






	
 



%
!"
(
(
)
%(
 





%&
$(

#




 

 "#




!)
$&
'

#

&
!)
#
('

47 
p<0.05 for 6H2 versus WT, or for knockdown versus scrambled. 
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Figure 3.5 
 
Figure 3.5 Intronic non-coding RNA expression is disrupted in 6H2 cells. (A,B) WT 
and 6H2 cells (A) and scrambled control and knockdown cells (B) were untreated or 
supplemented with palm for 48 h. Small RNA was harvested and used in RNase 
protection assay with 32P-labeled rpL13a snoRNA probes or miR-16 probe as control. 
Protected probe was analyzed by autoradiography. (C,D,E,F)	  WT and 6H2 cells were 
untreated or treated with palm for 9 h. Cells were separated into cytosolic (CYT) and 
nuclear (NUC) fractions by sequential detergent solubilization. (C) Fractions were 
analyzed by western blotting or PCR visualization for cytosolic markers, hsp90 and 
tRNAGlu, and for nuclear markers, fibrillarin and U6 RNA. (D) Molar quantities of 
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rpL13a snoRNAs from cytosolic and nuclear fractions were quantified relative to a 
standard curve. Plot represents relative molar ratio. (E,F) Total RNA was prepared from 
the cytosolic (E) and nuclear (F) fractions and analyzed for rpL13a snoRNA abundance 
relative to β-actin by qRT-PCR. (G) Total RNA was prepared from nuclear fractions of 
WT and 6H2 cells and analyzed for intronic and non-intronic box C/D snoRNAs; intronic 
box H/ACA snoRNAs; and splicing-dependent/Drosha-independent intronic and non-
intronic miRNAs. All data are expressed as mean ± SE for three independent 
experiments. *, p < 0.05 for 6H2 versus WT. 
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Figure 3.6 
 
Figure 3.6 SmD3 knockdown disrupts U4 and U5 snRNPs. (A,B,C,D) NIH 3T3 cells 
were transfected with LNA/DNA oligonucleotides specifically targeting GFP or SmD3. 
(A) Protein expression in GFP and SmD3 transfected cells was determined by western 
blotting and quantified by densitometry. Representative blot shown for SmD3 and β-
actin control. (B) Nuclear RNA was isolated and analyzed for SmD3 mRNA and rpL13a 
snoRNA expression by qRT-PCR relative to 36B4. (C) Total RNA was isolated and 
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analyzed for snRNA expression relative to 36B4 by qRT-PCR. (D) Cell lysates were 
immunoprecipitated using α-Sm Y12 antibody or IgG control. RNA was isolated 
following immunoprecipitation and analyzed by qRT-PCR for α-Sm immunoprecipitated 
snRNA relative to control (IgG) precipitated. (E,F,G,H) NIH 3T3 cells were transfected 
with control (contr) siRNA or siRNA targeting SmB. (E) Protein expression in control and 
SmB siRNA cells was determined by western blotting and quantified by densitometry. 
Representative blot shown for SmB and β-actin control. (F) Nuclear RNA was isolated 
and analyzed for SmB and rpL13a snoRNA expression by qRT-PCR relative to 36B4. 
(G) Control and SmB siRNA cells were incubated with 500 µM palm for 24 h or 48 h. 
Cell death was quantified by PI staining and flow cytometry. (H) Total RNA was isolated 
and analyzed for snRNA expression by qRT-PCR relative to 36B4. Data are expressed 
as mean ± SE for three independent experiments. *, p < 0.05 SmD3 versus GFP or 
SmB versus control; ns, not significant. 
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Figure 3.7 
 
Figure 3.7 Host gene expression is normal in 6H2 cells. (A) rpL13a locus is shown 
with non-coding region in black lines, exons in black boxes and snoRNAs in gray ovals. 
Location of primers for qPCR analysis of pre-mRNA and mRNA are noted. (B) WT and 
6H2 cells were untreated (UT) or treated with palm for 9 h. For analysis of rpL13a pre-
mRNA expression, total RNA was reverse transcribed using random hexamers, and 
amplified using primers that span the junction between exon 3 and intron 3. For analysis 
of rpL13a mRNA expression, total RNA was transcribed using oligo-dT and amplified 
using primers that span exon-exon junctions. Primer pairs are as indicated in (A). (C) 
WT and 6H2 cells were transfected with a split luciferase reporter containing a β-globin 
A B
D E
F
Snhg5 Nop56 U60hg RPL5 Snhg3 RPS2 EIF5 VWA5B2 PKD1
0.0
0.5
1.0
1.5
nc
R
N
A
 h
os
t g
en
e:
 
6-
ac
tin
 R
N
A
WT
6H2
ns
(U50) (U57) (U60) (U21) (U17b) (U64) (ACA28) (miR1224)(miR1225)
intronic box C/D snoRNA 
host genes
intronic box H/ACA snoRNA 
host genes
mirtron host genes
ns nsnsnsnsns ns ns
WT 6H2 WT 6H2
0.0
0.5
1.0
1.5
sno 5 sno
splicing reporter
snoRNA
*
sn
oR
N
A
: l
uc
ex
pr
es
si
on
 (r
el
 u
ni
ts
)
WT 6H2 WT 6H2
0.0
0.5
1.0
1.5
2.0
5 snosno
splicing reporter
ns ns
lucluc
lu
m
in
es
ce
nc
e 
/ l
uc
ex
pr
es
si
on
 (r
el
 u
ni
ts
)
lucluc
WT 6H2
0.0
0.5
1.0
1.5
UT
palm
*
clor
*
ns
ns
ns
lu
m
in
es
ce
nc
e 
/ l
uc
ex
pr
es
si
on
 (r
el
 u
ni
ts
)
C
Ex3/Int3 Ex2/3 Ex4/5 Ex5/6 Ex6/7 Ex7/8 Ex3/Int3 Ex7/8
0.0
0.5
1.0
1.5
R
N
A
:6
-a
ct
in
 R
N
A
(re
l u
ni
ts
)
ns
WT
6H2
ns ns ns ns ns ns ns
UT palm
    
      	 

  	
 	

53 
intron. 24 h post-transfection, cells were untreated or treated with palm or clortrimazole 
(clor) for 4 h. Luminescence was measured and normalized to luciferase pre-mRNA 
expression by qPCR. (D,E) WT and 6H2 cells were transfected with a split luciferase 
construct containing the intact U32a intron (sno) or the U32a intron lacking the 83 
nucleotide U32a snoRNA (Δsno). Total RNA was analyzed for luciferase pre-mRNA and 
U32a snoRNA expression. Luminescence (D) and U32a snoRNA (E) were normalized 
to luciferase pre-mRNA expression. Note that sequences differences between the 
murine intronic sequences in the reporter construct and endogenous hamster 
sequences enable discrimination between exogenous murine and endogenous hamster 
snoRNAs using species-specific PCR primers. (F) Total RNA was prepared from WT 
and 6H2 cells and analyzed for host genes of endogenous intron-encoded snoRNAs 
and mirtrons by qRT-PCR relative to β-actin mRNA. All data are expressed as mean ± 
SE for three independent experiments. *, p < 0.05; ns, not significant. 
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Figure 3.8 
 
Figure 3.8 Alternative splicing is normal in 6H2 cells. Exon array analysis was used 
to predict differences in alternative splicing. Relative probeset intensity values from 
exon array were plotted for SmD3 LNA versus GFP LNA transfected cells using data 
from three independent samples/arrays for each condition.  
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Figure 3.9 
 
Figure 3.9 SnoRNA-containing intron lariats are decreased in 6H2 cells. (A) WT 
and 6H2 CHO cells were untreated or treated with palm for 9 h. Nuclear RNA was 
isolated and reverse transcribed using random hexamers. rpL13a intron lariat 
abundance was determined by qRT-PCR using primers reading across branch points 
(red arrows in diagram). Quantification of lariat PCR product is normalized to β-actin 
mRNA. (B,C) PCR products generated by intron lariat primers in CHO WT cells were 
visualized on 2% agarose gel (B) or cloned and sequenced (C). (B) Lanes with cDNA 
(+) contain RT product as template. Lanes without cDNA (-) were negative control PCR 
reactions with no RT product provided as template. (C) Sequencing revealed the branch 
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site adenosine (red) for each intron. Branch site nucleotides showing conservation 
(uppercase) are indicated. (D) WT and 6H2 cells were transfected with a split luciferase 
construct containing the intact murine U32a intron (sno) or the U32a intron lacking the 
83 nucleotide U32a snoRNA (Δsno). Intron lariat abundance was determined by qRT-
PCR using primers specific for the murine lariat sequences and normalized to luciferase 
pre-mRNA expression. All data are expressed as mean ± SE for three independent 
experiments. *, p < 0.05; ns, not significant. 
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Figure 3.10 
 
Figure 3.10 Role for SmD3 in snoRNA production. A model for SmD3 role in 
snoRNA production is shown. Open boxes denote exons; black lines denote intronic 
sequences; and snoRNA sequences are shown in yellow and blue. Colored balls 
represent snRNPs. In the presence of wild type levels of SmD3, the complement of 
snRNAs is sufficient to support splicing of pre-mRNAs into mature mRNAs and intron 
lariats that are sufficiently long-lived to produce snoRNAs. While haploinsufficiency of 
SmD3 is able to support wild type levels of mRNA production from splicing, associated 
decreases in the abundance of the of U4 and U5 snRNPs results in decreased intron 
lariat abundance and decreased levels of intronic snoRNAs (yellow, blue).	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CHAPTER 4 
Superoxide triggers cytosolic snoRNA accumulation 
 
INTRODUCTION 
 Under physiological conditions, ROS serve a number of critical functions. 
Superoxide (O2-) and hydrogen peroxide (H2O2) are known to regulate gene expression 
by signaling through phosphatases, JAK/STATs, MAP kinases, and transcription factors 
including NF-κB (34). ROS levels are kept in check by antioxidant enzymes and 
scavengers including dismutases, peroxiredoxins, glutathione peroxidases, and 
catalase. 
 Under pathophysiological conditions, when ROS generation exceeds cellular 
antioxidant defenses, oxidative stress results. The rpL13a snoRNAs are critical for ROS 
propagation during lipotoxic stress (72). NADPH oxidase activation is also important for 
FFA-induced oxidative stress, since inhibition of NADPH oxidase blocks lipotoxic cell 
death (11). Lipotoxic conditions can activate NADPH oxidase through ceramide 
synthesis or, in the absense of de novo ceramide synthesis, through protein kinase C 
(PKC) dependent pathways (45, 61).  
 Nox enzymes generate ROS by transferring electrons from NADPH to molecular 
oxygen. O2- is the primary product of Nox enzymes, and Nox4 is also able to produce 
H2O2. In many cell types including cardiomyocytes and cardiac fibroblasts, Nox2 and 
Nox4 are the predominant NADPH oxidases (67). Nox2 is normally quiescent, and its 
activation requires stimulus-induced membrane translocation of cytosolic regulatory 
subunits, including p47phox, p67phox, p40phox, and Rac1, a small GTPase. This 
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translocation is triggered by phosphorylation of p47phox by PKC (2). Nox4 is 
constitutively active when assembled as a heterodimer with p22phox. Nox4 ROS 
generation does not require association of cytosolic factors but is regulated at the gene 
expression level. 
Given that NADPH oxidase activation is a critical contributor to ROS generation 
during lipotoxicity, we hypothesized that specific ROS (e.g. O2-) may be linked to ROS 
propagation driven by the rpL13a snoRNAs. Here, we demonstrate a link between O2- 
induction and cytosolic rpL13a snoRNA accumulation. Our results extend the known 
relationship between ROS and rpL13a snoRNAs, suggesting a role for these snoRNAs 
in additional oxidative stress-related diseases. 
 
RESULTS 
Palmitate-induced superoxide precedes cytosolic snoRNA accumulation. 
Following palmitate treatment, rpL13a snoRNAs accumulate in the cytosol in a time-
dependent fashion in H9c2 cells (Figure 4.1A). By 6 hr following palmitate treatment, 
U32a, U33, and U34 are elevated ~2-fold in the cytosol, and U35a is elevated 1.5-fold. 
Since rpL13a snoRNAs are critical for ROS propagation during lipotoxicity, we 
hypothesized that rpL13a snoRNAs participate in a feed-forward ROS cascade initiated 
by ROS production following palmitate treatment. O2- is produced during lipotoxicity 
through NADPH oxidase (31). To test how quickly O2- is generated following palmitate 
treatment, we quantified O2- production in cells treated with palmitate in the presence of 
the O2- detector MCLA. Palmitate treatment rapidly raised O2- levels, and levels 
remained high compared to untreated cells over the course of 1 hr (Figure 4.1B) These 
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data indicate O2- induction is an early response to lipotoxicity and precedes cytosolic 
snoRNA accumulation. 
 
Direct superoxide induction causes rapid cytosolic snoRNA accumulation. To test 
whether O2- generation can induce cytosolic snoRNA accumulation independent of 
metabolic stress, we treated H9c2 cells with chemical inducers of O2-. Since O2- can be 
rapidly dismutated into H2O2, we initially examined the relative production of H2O2 
following treatment with menadione and doxorubicin. We loaded cells with DCF to track 
H2O2 generation and observed a dose dependent increase in DCF signal following 
menadione treatment (Figure 4.2B). In comparison, doxorubicin generated less than 
half the H2O2 of menadione even at high concentrations, suggesting doxorubicin is not a 
potent inducer of H2O2. 
 We confirmed that doxorubicin generates O2- in H9c2 cells by treating cells with 
doxorubicin for 1 hr followed by O2- detection by MCLA. We detected a dose dependent 
increase in O2- production (Figure 4.3A). Since doxorubicin generates O2- while only 
producing modest levels of H2O2, we wanted to test whether doxorubicin could induce 
cytosolic snoRNA accumulation. Following treatment with doxorubicin, we observed 
rapid accumulation of rpL13a snoRNAs in the cytosol (Figure 4.3B). U32a, U33, and 
U34 were up-regulated by at least 2.5 fold as early as 20 min following palmitate 
treatment. Additionally, the magnitude of cytosolic snoRNA expression was higher than 
observed following palmitate treatment in H9c2 cells or other cell types (72, 94). These 
data suggest that direct O2- induction can rapidly and robustly induce cytosolic snoRNA 
accumulation.  
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Superoxide levels correlate with cytosolic snoRNA accumulation. Conversion of 
O2- to H2O2 is predominately regulated by superoxide dismutases (SOD). Isoforms of 
these antioxidant enzymes are located throughout the cell and extracellular space. 
SOD1 is located in the mitochondrial intermembrane space and cytosol, SOD2 is 
located in the mitochondrial matrix, and SOD3 is tethered to the extracellular matrix 
(95). We hypothesized that chemical manipulation of these enzymes would alter O2- 
levels and subsequently alter levels of rpL13a snoRNAs in the cytosol. To increase 
levels of O2-, we co-treated cells with doxorubicin and diethyldithiocarbamate (DETC), 
an SOD inhibitor (Figure 4.4A) We also co-treated cells with doxorubicin and MnTBAP, 
an SOD mimic, to increase O2- scavenging and subsequently decrease O2- levels 
(Figure 4.4A). RpL13a cytosolic snoRNA expression correlated with these changes in 
O2- levels (Figure 4.4B). Relative to doxorubicin treatment alone, U32a, U33, and U34 
all showed increased cytosolic accumulation following co-treatment with doxorubicin 
and DETC and decreased cytosolic accumulation following co-treatment with 
doxorubicin and MnTBAP. U35a was unaltered by doxorubicin treatment but was up-
regulated following co-treatment with doxorubicin and DETC. Although doxorubicin co-
treatment with MnTBAP lowered cytosolic snoRNA levels relative to doxorubicin 
treatment alone, snoRNA levels remained higher in the presence of doxorubicin and 
MnTBAP than in H2O-treated control cells, despite lower O2- levels in the MnTBAP 
treated cells. These data suggest O2- contributes to cytosolic snoRNA localization, but 
other factors likely contribute and may be important for localization of U35a in particular. 
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CONCLUSIONS 
 The rpL13a snoRNAs are critical for ROS propagation in response to metabolic 
stress. Cytosolic localization of these snoRNAs is thought to be an important feature of 
the function of these non-coding RNAs during lipid-induced oxidative stress. Here, we 
demonstrate a link between ROS induction and cytosolic snoRNA accumulation. 
Specifically, O2- induction precedes cytosolic snoRNA accumulation under lipotoxic 
conditions. Doxorubicin induced O2- also causes rpL13a snoRNAs to localize to the 
cytosol independent of metabolic stress.  Manipulation of O2- demonstrates that O2- 
levels directly correlate with cytosolic snoRNA expression. Our data are consistent with 
a model in which palmitate and direct O2- inducers stimulate higher levels of O2- in the 
cells. This O2- provides a signal to nuclear snoRNAs, through a pathway yet to be 
elucidated, causing translocation of snoRNAs to the cytosol (Figure 4.5) 
 Additional experimentation will be required to determine the source of O2- under 
lipotoxic conditions. We hypothesize that NADPH oxidase is that source of O2-. 
Inhibition of NADPH oxidase or Nox enzyme knockdown will enable determination of the 
role of NADPH oxidase in cytosolic snoRNA accumulation. Apocynin is an NADPH 
oxidase inhibitor that prevents the assembly of NADPH oxidase subunits. Diphenylene 
iodium (DPI) is a non-specific inhibitor of flavoenzymes including NADPH oxidase, 
quinone oxidoreductase, cytochrome P450 reductase, and nitric oxide synthase (59). 
Inhibition with either of apocynin or DPI could be used to test whether NADPH oxidase 
is generally involved in cytosolic snoRNA localization. Additionally, directed knockdown 
of Nox2, p22phox, or p47phox would help elucidate whether specific NADPH oxidase 
components are related to snoRNA localization. Nox2 knockdown would directly target 
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a predominant source of O2-. Knockdown of p22phox would test whether any of the Nox 
enzymes 1-4 are involved, and knockdown of p47phox would test whether a key cytosolic 
component required for Nox1-3 activity is related to snoRNA expression. 
 Additionally, we propose that palmitate-induced oxidative damage is amplified by 
cytosolic snoRNA accumulation (72). Following O2- reduction by MnTBAP or NADPH 
oxidase inhibition/knockdown, we hypothesize that oxidative damage will be reduced 
during lipotoxicity. To test this hypothesis, protein carbonylation and palmitate-induction 
of cell death will be quantified in future studies in cells expressing various levels of O2-. 
 Finally, it will be of great interest to determine the specificity of relationship 
between specific ROS species and the broader genomic program of snoRNAs. We 
hypothesize that specific ROS regulate different snoRNAs. Preliminary data from our 
lab suggests a number of additional snoRNAs are found in the cytosol during lipotoxicity 
(not shown). Even though U32a, U33, U34, and U35a are produced from the same pre-
mRNA, our data suggest that the kinetics or the specificity of ROS-stimulated 
relocalization to the cytosol differs among these snoRNAs. Since oxidative stress is the 
result of the propagation of various ROS induced at different times, we propose that 
individual snoRNAs respond specifically to different ROS. To test this hypothesis, we 
will use a custom Agilent microarray developed in our lab that enables quantitative 
detection of approximately 300 known and predicted snoRNAs to determine the 
program of snoRNAs that accumulate in the cytosol following specific induction of O2- 
vs. H2O2 vs. other ROS species. Changes identified in snoRNA expression will be 
confirmed by qPCR and in situ hybridization. 
64 
 Together, our data suggest an intricate connection between ROS and snoRNA 
localization. Future studies will be needed to elucidate the mechanisms through which 
O2- and other ROS signal to snoRNAs and will broaden our understanding of the 
contributions of these non-coding RNAs to metabolic stress.  
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Figure 4.1 
 
Figure 4.1 Palmitate induces superoxide. (A) H9c2 cardiomyoblast cells were treated 
with BSA or treated with 500 µM palmitate for 3, 6, 12, or 24 h. Cytosolic fractions were 
isolated from cells by sequential detergent solubilization. Total RNA was prepared from 
the cytosolic fraction and analyzed for rpL13a snoRNA and mRNA abundance relative 
to 36B4 by qRT-PCR. Graph shows mean ± SE (n = 3) from a representative 
experiment. (B) H9c2 cells were untreated (UT) or treated with palmitate (palm) in 2-
methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazol[1,2-A]pyrazin-3-one, hydrochloride 
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(MCLA) buffer for 60 min. Luminescence was measured every 30 sec and normalized to 
a superoxide dismutase-treated control. 
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Figure 4.2 
 
Figure 4.2 Doxorubicin is not a potent H2O2 inducer. (A) Superoxide (O2-) is rapidly 
dismutated by the antioxidant enzyme superoxide dismutase (SOD), leading to the 
formation of hydrogen peroxide (H2O2) and molecular oxygen. (B,C) H9c2 cells pre-
loaded with CM-H2DCFDA (DCF) dye were untreated (UT) or treated with menadione 
(mena) or doxorubicin (dox) for 60 min. H2O2 induction was assessed by DCF 
fluorescence every 2 min using a Tecan microplate reader.
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Figure 4.3 
 
Figure 4.3 Doxorubicin induces rapid cytosolic rpL13a snoRNA accumulation. (A) 
H9c2 cells were untreated (UT) or treated with doxorubicin (dox) for 60 min. Superoxide 
induction was assessed by MCLA. Luminescence was measured every 30 sec and 
integrated luminescence over 3 min is reported normalized to an SOD treated control. 
(B) H9c2 cells were untreated (UT) or treated with 20 µM doxorubicin for 20 min, 60 
min, 12 h, or 24 h. Cytosolic fractions were isolated from cells by sequential detergent 
solubilization. Total RNA was prepared from the cytosolic fraction and analyzed for 
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rpL13a snoRNA and mRNA abundance relative to 36B4 by qRT-PCR. Graph shows 
mean ± SE (n = 3) from a representative experiment. 
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Figure 4.4 
 
 
Figure 4.4 Manipulation of superoxide alters cytosolic rpL13a snoRNA 
accumulation. (A,B) H9c2 cells were untreated (UT) or treated with 5 µM doxorubicin 
(dox) for 60 min. Cells were co-treated with H2O, 400 µM diethyldithiocarbamic acid 
(DETC), or 400 µM manganese(III) tetrakis(4-benzoic acid)porphyrin chloride 
(MnTBAP). (A) Superoxide induction was assessed by MCLA. Luminescence was 
measured every 30 sec and integrated luminescence over 3 min is reported normalized 
to an SOD treated control. (B) Cytosolic fractions were isolated from cells by sequential 
detergent solubilization. Total RNA was prepared from the cytosolic fraction and 
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analyzed for rpL13a snoRNA and mRNA abundance relative to 36B4 by qRT-PCR. 
Graph shows mean ± SE from a representative experiment.	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Figure 4.5 
 
 
Figure 4.5 Superoxide is linked to cytoplasmic snoRNA accumulation. A model for 
the role of superoxide in cytoplasmic snoRNA accumulation is shown. Treatment with 
palmitate or doxorubicin causes increased levels of superoxide radicals. Through an 
unknown mechanism, superoxide signals nuclear snoRNAs to accumulate in the 
cytoplasm. SnoRNAs are shown in green, purple, yellow, and blue.  	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CHAPTER 5 
Discussion 
Genetic screens provide powerful approaches to dissect cell biological 
phenomena. Inherent in this approach is the advantage that genes are identified on the 
basis of their functional contributions to the pathway of study. Since multiple mutations 
may affect different components in the pathway, genetic approaches also have the 
ability to elucidate interacting elements. Our screen for mutations that render cells 
resistant to lipotoxicity identified rpL13a snoRNAs as critical mediators of metabolic 
stress. Identification of a second, independent mutation that disrupts the expression of 
these snoRNAs highlights the importance of ncRNAs in lipotoxicity. With this second 
mutant, we identified SmD3 as an upstream regulatory element necessary for the 
expression of rpL13a snoRNAs. Thus, in an unbiased genetic screen, we identified 
unexpected elements of the lipotoxic response. 
Phenotypic characterization of the 6F2 and 6H2 mutants revealed that rpL13a 
snoRNAs are also involved in the general response to oxidative stress. Previous 
biochemical studies in diverse cell types have correlated lipotoxic stress with the 
generation of ROS (7, 45). The rpL13a snoRNAs provide evidence of a functional link 
between the progress of lipotoxic cell death and the deleterious cellular response to 
oxidative stress. While transcriptional, posttranslational, and signaling mechanisms are 
known to contribute to the cellular response to oxidative stress (33, 41), our studies are 
the first to implicate snoRNAs in the response to environmental perturbations. 
A key observation that facilitated our understanding of the contributions of the 
rpL13a locus to lipotoxicity was the extent of sequence conservation of this gene 
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beyond the protein-coding exons. Four box C/D snoRNAs, U32a, U33, U34, and U35a 
located in rpL13a introns 2, 4, 5, and 6, respectively, are highly conserved across 
mammalian species both in terms of their primary sequence and their position within the 
locus. While box C/D snoRNAs function as guides for 2’-O-methylation in yeast (Lowe 
and Eddy, 1999), the sequences of the U32a, U33, U34, and U35a snoRNAs and their 
genomic organization diverge substantially from yeast to mammals. In mammals, a role 
in the modification of ribosomal RNAs has not been demonstrated for these snoRNAs. 
We show here in a stable mutant cell line that decreased basal expression of U32a, 
U33, and U35a snoRNAs and loss of palmitate induction of these snoRNAs is not 
associated with changes in 2’-O-methylation of predicted rRNA targets, yet is 
associated with resistance to lipotoxicity. While it is possible that these snoRNAs 
contain more than one functional guide sequence to target multiple substrates including 
rRNAs (13, 110), their accumulation in the cytosol during lipotoxicity suggests a non-
nucleolar function for these snoRNAs.  
Movement of snoRNAs to the cytosol is not without precedent, since the 
independently transcribed box C/D snoRNA, U8, has been shown to be exported from 
the nucleus (121). The present study provides the first direct evidence for intronic 
snoRNAs in the cytosol. Our data are most consistent with a model in which the rpL13a 
snoRNAs function in lipotoxicity and oxidative stress response pathways as non-
canonical box C/D snoRNAs. Our results demonstrate that U32a, U33, and U35a 
function coordinately in propagation of oxidative stress in vivo. Thus, our study provides 
evidence for snoRNA regulation of metabolic stress response pathways.  
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Cytosolic functions of snoRNAs 
 The cytosolic function of snoRNAs has yet to be elucidated. We hypothesize that 
snoRNAs serve to guide the modification of cytosolic target RNAs during metabolic 
stress. Cytosolic ncRNAs, particularly tRNAs, are known targets for modification. tRNAs 
are subject to over 75 different modifications throughout their sequence. Modifications 
to the anticodon loop can influence the recognition of codons and maintenance of the 
translational reading frame (32). Although pre-mRNA are known to undergo 5’ m7G 
capping, 3’ polyadenylation, and RNA splicing, modification of individual nucleotides 
within cytosolic mRNAs is not well described. The abundance of modifications in tRNA, 
rRNA, and snRNA raises the possibility that mRNAs might also be modified. 
 SnoRNAs could function in the regulation of mRNA translation, possibly through 
targeted modification or sequestration of specific mRNAs. Recently, it was 
demonstrated that targeted pseudouridylation of termination codons suppresses 
translation termination in vitro (48). Given the manifold of changes in gene expression 
during the lipotoxic and oxidative stress responses (10), the coordinate function of the 
rpL13a snoRNAs (72), lack of a well-defined long stretch of perfect antisense homology 
to targets in snoRNAs (53), and the possibility that snoRNA-directed modifications of 
RNA targets may not be reflected by changes in abundance of those RNAs, 
identification of specific targets for each of these snoRNAs will be a complex task and 
the subject of future investigations. To identify individual targets of rpL13a snoRNAs, 
transfection of cells with synthetic biotin-labeled snoRNA molecules could facilitate pull-
down of RNA species that interact specifically with rpL13a snoRNAs. While initial 
approaches may utilize biochemical isolation of specific snoRNA-targetRNA complexes, 
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it will also be of great interest to examine 2’-O-methylation and pseudouridylation on a 
genome-wide level. 
 Identification of precise snoRNA localization within the cytosol will also be useful 
for understanding the function of snoRNAs during metabolic stress. Moreover, our initial 
studies suggest that snoRNAs are subject to cellular export. Treatment of cultured cells 
with palmitate leads to detectable snoRNA expression in culture media. Additionally, 
snoRNAs are stably expressed in human and mouse serum, and treatment of 12-week-
old mice with LPS results in increased serum snoRNA expression (not shown). Thus, 
snoRNAs may be readily exported from cells. A number of recent studies have shown 
that miRNAs are released from cells after cell death, in apoptotic bodies, through 
microvesicles including exosomes, and as part of protein complexes giving precedence 
for extracellular ncRNAs (106, 113, 114). If future studies confirm a role for snoRNA 
secretion in response to lipotoxicity and oxidative stress, circulating snoRNAs could 
ultimately serve as a biomarkers for diseases characterized by oxidative stress.  
 
Regulation of snoRNA processing 
Identification of SmD3 through our genetic screen unmasks a previously 
unsuspected role for this protein in production of intronic snoRNAs. The precise 
mechanisms through which SmD3 regulates intronic snoRNA expression remain to be 
determined. One possibility is that SmD3 has a direct role in snoRNA biogenesis 
unrelated to its function in snRNPs. Unlike SmD3 haploinsufficient cells, SmB 
knockdown cells remain sensitive to palmitate-induced death suggesting that SmD3 has 
a function distinct from other Sm protein family members. Additionally, SmD3 has been 
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observed to function independently from the Sm core in the cytoplasm (30). SmD3 has 
also been previously shown to bind small Cajal body RNAs (scaRNAs), a class of 
snoRNAs specifically localizing to Cajal bodies, and human telomerase (hTR) via a CAB 
box site (28). However, H/ACA snoRNAs U17b and U64, which are affected by 
haploinsufficiency of SmD3, both lack CAB box sequences. Additional studies will be 
required to decipher whether SmD3 can function independently from the Sm core during 
snoRNA biogenesis. 
Our data are most consistent with a model in which SmD3 does not directly 
interact with the maturing snoRNA during processing, but rather controls processing 
indirectly through a role in snRNP assembly and/or stabilization (Figure 3.10). 
Knockdown of SmD3 results in decreased expression of U4 and U5 snRNPs that are 
required for precatalytic spliceosome formation and initiation of an active spliceosome 
capable of intron lariat formation (68). Furthermore, reduced expression of snoRNA 
lariat precursors, resulting from decreased lariat production or stability, leads to 
decreased abundance of the mature intronic snoRNAs and failure to support their 
induction during lipotoxicity in 6H2 cells. These differences in intron lariat abundance 
and snRNP expression suggest that the phenotype observed in 6H2 cells is related to 
spliceosomal machinery, even though haploinsufficiency of SmD3 is sufficient to 
maintain production of mRNAs.  
We also observed that wild type levels of SmD3 are critical for the ability to 
express a number of intronic non-coding RNA elements including other box C/D 
snoRNAs, H/ACA snoRNAs, and mirtrons. These ncRNAs do not share significant 
sequence similarities and each assembles with a unique set of proteins during 
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processing, making it unlikely that SmD3 directly recognizes and associates with the 
nascent RNP. It has been shown that the C-terminal tail of SmD3 interacts with the 
central Tudor domain of splicing factor SPF30 (62), indicating that SmD3 may be 
important for the assembly of splicing factors specific to individual snRNPs. Individual 
Sm proteins may be critical for the assembly of specific factors within different snRNPs 
consistent with the different snRNA expression profiles observed following SmD3 
knockdown versus SmB knockdown. In follow up, it will be of interest to determine 
whether Sm protein-splicing factor interactions are critical for SmD3’s role in snRNP 
assembly and/or stabilization and to better define the distinct but overlapping roles of 
SmD3 and SmB in assembly and stabilization of snRNPs.  
 
Regulation of snoRNA localization 
SnoRNAs are processed in the nucleus and canonically reside within the 
nucleolus. Our studies indicate that nuclear snoRNA levels are multiple orders of 
magnitude higher in the nucleus than the cytoplasm even during metabolic stress. 
Unlike snRNAs, snoRNAs are not thought to undergo a cytosolic phase during 
maturation (69), suggesting that accumulation of snoRNAs in the cytosol requires an 
active mechanism. We demonstrate that O2- induction precedes cytosolic snoRNA 
accumulation consistent with the hypothesis that O2- functions as an upstream trigger of 
snoRNA translocation from the nucleus to the cytosol. O2- participates in multiple 
signaling pathways (34). ROS driven signal transduction includes induction of gene 
expression, protein phosphorylation, and alteration of redox status (73). Examination of 
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O2- signaling pathways, particularly in the nucleus, will be of great interest in future 
studies of ROS regulated snoRNA localization. 
O2- diffuses only short distances before reacting with a target, so it is likely that 
the source of O2- related to snoRNAs is generated in close proximity to its intended 
target. Although NADPH oxidases are implicated to be involved in lipotoxicity, the 
source of O2- leading to cytosolic snoRNAs remains to be elucidated. Nox enzymes 
each have distinct subcellular localizations. Nox2 is found predominantly on the plasma 
membrane, whereas Nox4 is located in intracellular membranes. O2- can also be 
generated from several additional sources, including xanthine oxidases, peroxidases, 
lipoxygenases, cyclooxygenases, and mitochondrial respiratory chain complexes (129). 
Determination of the source of O2- will help elucidate how O2- is linked to cytosolic 
snoRNA accumulation. 	  
Summary 
Together, our data demonstrate that snoRNAs are highly regulated in response 
to metabolic stress and contribute significantly to the pathogenesis of oxidative stress. 
To carry out this role, snoRNAs must be efficiently processed and properly localized. 
Elucidation of the regulatory steps in snoRNA production and localization and 
identification of targets for non-canonical snoRNAs will advance our understanding of 
the pathogenesis of common human diseases. Moreover, regulation of snoRNAs 
provides potential therapeutic targets for oxidative stress-related diseases including 
type 2 diabetes. 	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CHAPTER 6 
Materials and Methods 
 
Materials. Palmitate was from Nu-Chek Prep. 14C-palmitate and α-32P-UTP were from 
PerkinElmer Life Sciences. Camptothecin, actinomycin D, hygromycin, and MnTBAP 
were from Calbiochem. Staurosporine, H2O2, menadione, phloretin, clotrimazole, 
doxorubicin, and DETC were from Sigma-Aldrich. Fatty acid-free bovine serum albumin 
(BSA) was from SeraCare. Propidium iodide, CM-H2DCFDA, DHE, and MCLA were 
from Invitrogen. All synthetic oligonucleotides were from IDT (see Table 1 for primer 
sequences). Restriction enzymes were from New England BioLabs. 
 
Cell Culture. CHO-K1 cells (American Type Culture Collection) and CHO-derived cell 
lines were maintained in high glucose (4.5 mg/ml Dulbecco’s modified Eagle’s medium 
and Ham’s F-12 nutrient mixture (1:1)) media with 5% non-inactivated fetal bovine 
serum, 2 mM L-glutamine, 50 units/ml penicillin G sodium, 50 units/ml streptomycin 
sulfate, and 1 mM sodium pyruvate. C2C12 myoblasts (American Type Culture 
Collection) were maintained in high glucose (4.5 mg/ml Dulbecco’s modified Eagle’s) 
medium with 10% heat-inactivated fetal bovine serum, 50 units/ml penicillin G sodium, 
and 50 units/ml streptomycin sulfate. NIH 3T3 cells (American Type Culture Collection) 
were maintained in high glucose (4.5 mg/ml Dulbecco’s modified Eagle’s medium) 
media with 10% bovine calf serum, 2 mM L-glutamine, 50 units/ml penicillin G sodium, 
and 50 units/ml streptomycin sulfate. H9c2 cardiomyoblast cells (American Type Culture 
Collection) were maintained in high glucose (4.5 mg/ml Dulbecco’s modified Eagle’s 
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medium) media with 10% fetal bovine serum, 2 mM L-glutamine, 50 units/ml penicillin G 
sodium, and 50 units/ml streptomycin sulfate. For lipotoxicity experiments, cell culture 
media was supplemented with 500 µM (WT CHO and 6H2) or 250 µM (shRNA 
transfected cells) palmitate complexed to BSA at a 2:1 M ratio, as described previously 
(61). For ROS induction, media was supplemented with the indicated concentrations of 
H2O2, menadione, or doxorubicin. 
 
Generation of CHO Cell Mutants. Vesicular stomatitis virus G protein pseudotyped 
murine retrovirus encoding the ROSAβgeo retroviral promoter trap was generated as 
described previously (26, 81). CHO cells were transduced with retrovirus at a low 
multiplicity of infection (1 integration per 10 genomes on average) and mutants were 
isolated as described previously (7). Number of retroviral insertions within the mutant 
cell genome was assessed by Southern blotting. Genomic DNA was digested with 
restriction enzymes, separated by agarose gel electrophoresis, transferred to nylon 
membranes, and probed with a 32P-labeled probe corresponding to the ROSAβgeo 
proviral sequence. 
 
Cell Death Assays. Cell death was assessed by membrane permeability to propidium 
iodide (PI) staining and flow cytometry (61). Following treatments, cells were harvested 
by trypsinization and stained with 1 µM PI. Analyses were performed on 104 
cells/sample. 
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14C Palmitate Uptake Assay. 2 × 106 cells were resuspended in 1 ml phosphate-
buffered saline (PBS) containing 500 µM 14C-palmitate complexed to 250 µM BSA and 
incubated for one minute at 37°C. Cells were washed with 10 ml PBS containing 0.1% 
BSA and 500 µM phloretin, filtered, and cell-associated 14C was quantified by 
scintillation counting. A parallel aliquot of cells was used for quantification of protein by 
bicinchoninic acid assay (Pierce). 
 
Identification of Trapped Gene. The endogenous gene disrupted by retroviral insertion 
was identified by 5’ rapid amplification of cDNA ends (RACE) using an oligonucleotide 
tag and ROSAβgeo sequences (SMART RACE cDNA amplification kit; Clontech). The 
5’ RACE product was TA cloned and sequenced, and tested for sequence similarity by 
NCBI BLAST. PCR was used to verify retroviral integration within the snrpD3 gene. 
 
Quantitative Real Time PCR (qPCR). RNA was isolated using TRIzol or TRIzol LS 
reagent (Invitrogen) and reverse transcribed to cDNA using the SuperScript III First-
strand Synthesis System for RT-PCR (Invitrogen) following the manufacturer’s 
instructions. Reverse transcription was performed with oligo(dT) to detect mRNA or 
random hexamers to detect pre-mRNA and intron lariats. For quantification of snoRNAs 
and pre-miRNAs, RNA was isolated using Trizol LS (Invitrogen). cDNA synthesis was 
primed with hairpin stem-loop oligos as previously described (72), with overhang 
complementarity to the 3’ end of the processed snoRNA or pre-miRNA. cDNA was 
amplified for 40 PCR cycles using SYBR Green PCR master mixture (Applied 
Biosystems) and 100 nM template specific primers in a ABI Prism 7500 Fast Real-Time 
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PCR System. Relative quantification of gene expression was performed using the 
comparative threshold method as described by the manufacturer.  
 
Flow Cytometry Detection of Reactive Oxygen Species. Cells (2 × 105) were plated 
in 12-well plates 24 h prior to various treatments. Cells were rinsed with PBS and 
incubated with PBS containing 0.5 mM MgCl2, 0.92 mM CaCl2, and 1µM (C2C12 cells) 
or 3 µM (CHO cells) 5-(and-6)-chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate, 
acetyl ester (CM-H2DCFDA, Invitrogen) in the dark at 37°C for 1 h. Cells were then 
rinsed with PBS, harvested by trypsinization, and quenched with culture media. Mean 
fluorescence was determined by flow cytometry on 104 cells/sample. 
 
Generation of SmD3 antibody. For immunoblot detection of SmD3, polyclonal rabbit 
anti-peptide antibody was generated from ProSci Incorporated. Animals were 
immunized with the unique peptide NH2-CTGEVYRGKLIEAED-OH (murine sequence) 
conjugated to KLH. Animals received six rounds of immunization followed by affinity 
purification of serum. 
 
Immunoblot Analyses. Whole cell protein lysates were prepared using RIPA buffer (50 
mM Tris-Cl, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 
and 5 mM EDTA) containing 1 mM phenylmethylsulfonyl fluoride and 1 × Protease 
Complete inhibitor mixture (Roche). Subcellular fractions were isolated by sequential 
detergent solubilization as described previously (40). Proteins (40 µg) were resolved by 
15% (for rpL13a, SmD3, and SmB) or 12% (for hsp90, fibrillarin, lamin B1, CHOP-10, 
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and β-actin) SDS-PAGE gel electrophoresis and transferred to nitrocellulose membrane 
(Whatman). Membranes were probed with antibodies to rpL13a (1:500), SmD3 (1:500), 
β-actin (A 2066, Sigma, 1:5000), hsp90 (SPA-846, Stressgen, 1:2000), fibrillarin (MMS-
581S, Covance, 1:500), lamin B1 (ab16048, Abcam, 1:1000), CHOP-10 (F-168, Santa 
Cruz, 1:500), and SmB (S0698, Sigma, 1:1000). Proteins were visualized using 
appropriate horseradish peroxidase-conjugated secondary antibodies (Jackson 
ImmunoResearch Laboratories, 1:10,000) and chemiluminescence reagents 
(PerkinElmer Life Sciences). Band intensities were quantified by densitometry (Bio-Rad 
Image Lab Software). 
 
snoRNA Probe Synthesis and RNase Digestion. Hamster- and mouse-specific 
snoRNA probes were generated with Megashortscript kit (Ambion). dsRNA templates 
were generated for probe for each rpL13a snoRNA by PCR amplification of cloned 
hamster or mouse rpL13a genomic sequence templates using primers containing the T7 
RNA polymerase promoter and used for in vitro RNA transcription of 32P-labeled 
snoRNA probes. miR-16 probes were synthesized using templates from mirVana 
miRNA Detection kit (Ambion). RNA was isolated from cells using mirVana miRNA 
isolation kit (Ambion) and hybridized to 32P-labeled RNA probes (mirVana miRNA 
Detection kit) overnight at 42-52°C, followed by RNase digestion and ethanol 
precipitation. RNA was separated by 10% or 15% polyacrylamide electrophoresis and 
visualized by autoradiography. 
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snoRNA Knockdown in vitro. Anti-sense oligos (ASOs) were designed to specifically 
target murine U32a, U33, U35a, U50, U57, and U60 snoRNA sequences according to 
Ideue et al. (44). For snoRNA “knock-down” experiments, 106 C2C12 myoblasts were 
nucleofected using Nucleofector Kit V (Amaxa) and a total of 600 pmol of ASO. 
 
Mapping of 2’-O-methyl modification by primer extension. Protocol was based on 
methods from Lowe and Eddy (64). Total RNA from Trizol extraction was annealed with 
32P end-labeled primers at 55°C for 4 min. Primer extension reactions were carried out 
in the presence of 50 mM Tris-Cl (pH 8.6), 60 mM NaCl, 9 mM MgCl2, 10 mM DTT, 1 
mM dNTP, and using avian myeloblastosis virus reverse transcriptase for 30 min at 
37°C. For rRNA sequencing, ddNTPs were used in individual reactions. For 2’-O’methyl 
mapping, reactions were carried in “High” (4mM), or “Low” (0.004 mM) dNTP 
concentrations, and 5 mM MgCl2. Reaction products were separated by 6% 
polyacrylamide electrophoresis (PAGE) and visualized by autoradiography. 
 
In situ hybridization of snoRNA probes. Synthesis and labeling of sense and 
antisense RNA probes were adapted from Darzacq et al. (16). C2C12 myoblasts were 
fixed in PBS containing 3% paraformaldehyde for 10 min, rinsed with PBS and 
permeabilized with 0.1% Triton X-100 for 10 min at room temperature. Cells were 
dehydrated serially in 70% ethanol, 95% ethanol, 100% ethanol and then air-dried. 
Sequence-specific oligonucleotide probes containing aminoallyl UTP were generated 
using the FISH Tag RNA Kit (Invitrogen) and labeled with an amine-reactive Alexa Fluor 
594 dye. Fluorescent probe (0.5 ng/µL) was denatured in hybridization buffer (2x SSC, 
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50% formamide, 10% dextran sulfate, 20 mM vanadyl ribonucleoside complexes) for 10 
min at 80°C. Cells were incubated with probe/hybridization buffer at 37°C for 10 hr, 
followed by sequential washes with 2x SSC, 1x SSC, 0.1x SSC all containing 1% SDS 
for 15 min each at 37°C. Nuclei were counter-stained using SYTOX Green (Invitrogen). 
Slides were mounted with SlowFade antifade reagent (Invitrogen). Images were 
captured on a ZEISS LSM 510 META confocal laser scanning microscope using 
constant pinhole size, detector gain, and offset for each probe. 
 
Mouse model of LPS-mediated oxidative stress and in vivo snoRNA knockdown. 
Female FVB mice were obtained from Charles River Laboratories and housed in 
Washington University Division of Comparative Medicine facilites. Diet was standard 6% 
fat breeding chow supplied ad libitum, and food was withheld at the time of LPS 
injection. Between 10 and 16 weeks of age, LPS was administered at 8 mg/kg 
intraperitoneally (IP), and animals were euthanized 12-24 h later. For in vivo knockdown 
experiments, LNA-modified ASOs were purchased from Exiqon and used to specifically 
target snoRNAs U32a, U33, and U35a. An ASO targeting GFP was used as a control. 
Mice were injected IP with a total of 2.5 mg/kg of LNA every other day for a total of three 
injections, and then dosed with LPS as above 48 h after the last LNA injection. 
Individual snoRNA ASO concentrations were 1.25, 0.5, and 0.75 mg/kg per dose, 
targeting U32a, U33, and U35a respectively (empirically determined based on 
knockdown). Liver tissue was divided and either snap-frozen in liquid nitrogen (for 
RNA), fixed in 10% neutral buffered formalin, or frozen in O.C.T. Compound (Tissue-
Tek). Experimental procedures were approved by the Washington University Animal 
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Studies Committee and were conducted in accordance with USDA Animal Welfare Act 
and the Public Health Service Policy for the Humane Care and Use of Laboratory 
Animals. 
 
In vivo detection of ROS. Formalin-fixed, paraffin-embedded samples or liver frozen in 
O.C.T. were mounted on slides in serial sections by the Washington University 
Anatomic and Molecular Pathology Core Lab. Detection of superoxide was performed 
on frozen sections using dihydroethidium (DHE; Invitrogen, Cat# D11347). Sections 
were incubated with 2 µM DHE for 30 min at 37°C or pre-treated with 200 Units/ml 
PEG-SOD (Sigma), followed by co-incubation of 2 µM DHE and 200 Units/ml PEG-SOD 
for 30 min at 37°C to verify the specificity of staining as indicated. For each animal (n = 
4 for GFP ASO; n = 5 for SNO ASO), intensity of staining was quantified in three 
independent fields from each of six sections using ImageJ software. Protein carbonyls 
were detected by immunoblot using the OxyBlot Protein Oxidation Detection Kit 
(Chemicon) according to the manufacturer’s instructions. Blots were quantified by 
densitometry using actin as a loading control. Tissue oxysterols (7-ketocholesterol, 7-
keto; 3β,5α,6β-cholestantriol, triol) per mg liver protein were quantified using LC/MS/MS 
as described (87). 
 
Generation of SmD3 shRNA Clones. Hamster snrpD3 cDNA sequence was used to 
design siRNA oligonucleotides using Ambion’s siRNA Target Finder Program 
(ambion.com/techlib/misc/siRNA_finder.html). shRNA oligonucleotides were designed 
from siRNA sequences that conferred effective knockdown in transient transfection 
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assays, and each was cloned into a pSilencer 4.1-CMV hygro vector (Ambion) 
containing a hygromycin resistance cassette. shRNA vectors were transfected into CHO 
cells with Lipofectamine 2000 reagent (Invitrogen). Cells were plated at limiting dilution 
and treated with 80 µg/ml hygromycin. Clonal lines were isolated, and SmD3 
knockdown assessed by immunoblot. 
 
Luciferase Plasmids and Transient Transfection. The split luciferase vector 
containing a β-globin intron was as described previously (128). All constructs generated 
by PCR or Quick-Change (Stratagene) mutagenesis were confirmed by sequencing. 
The β-globin intron in the split luciferase reporter was replaced with rpL13a intron 2 
containing snoRNA U32a or the rpL13a intron 2 lacking the 83 nucleotide U32a 
snoRNA sequence. Cells were transfected with Lipofectamine 2000 (Invitrogen) as per 
the manufacturer’s protocol and assayed 20 h post-transfection. 
 
Luciferase Detection. Cells (3 × 104) were plated in triplicate in 96-well plates. 
Following transfection of luciferase reporters as described above, cells were lysed with 
Dual-Glo Luciferase Reagent (Promega) according to the manufacturer’s protocol. 
Luciferase was detected using a Tecan Infinite M200 microplate reader and Magellan 
software. 
 
Microarray Sample Preparation and Data Analysis. NIH 3T3 cells (2 × 105) were 
plated in 6-well plates 24 h pre-transfection. Cells were transfected with 40 pmol 
LNA/DNA oligonucleotides specifically targeting GFP or SmD3 (Exiqon) using 
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lipofectamine 2000 (Invitrogen) as per the manufacturer’s protocol, and total RNA was 
harvested 23 h post-transfection using TRIzol reagent (Invitrogen). Resulting RNA was 
quantified by A260 and A280 readings using a Nanodrop spectrophotometer (Nanodrop 
Technologies) and qualitatively assessed using a BioAnalyzer 2100 (Agilent 
Technolgies). cDNA was prepared using the NuGen Ovation System and microarray 
data was generated with Affymetrix GeneChip Mouse Exon 1.0 ST arrays containing 
266,200 probesets in the Siteman Cancer Center Molecular and Genomic Analysis 
Core at Washington University. Partek Genomics Suite 6.5 was used to calculate 
probeset intensities from .CEL files using the RMA algorithm with default settings at 
both the gene level and probeset level. Probesets with RMA intensity below 3 across all 
samples were excluded to eliminate probesets with low expression levels. Alternative 
splicing multiway ANOVA was applied using Partek defaults to identify alternative 
splicing events with a false discovery rate (FDR) < 0.1. Core exon level analysis was 
also applied at the exon level to determine differential expression of exons not grouped 
by transcript. 
 
Transient Knockdown. For SmD3 knockdown, NIH 3T3 cells (2 × 105) were plated in 
6-well plates 24 h pre-transfection. Cells were transfected with 40 pmol LNA/DNA 
oligonucleotides specifically targeting GFP or SmD3 (Exiqon) using lipofectamine 2000 
(Invitrogen) as per the manufacturer’s protocol, and RNA was harvested 23 h post-
transfection. For SmB knockdown, NIH 3T3 cells (1 × 105) were plated in 6-well plates 
24 h pre-transfection. Cells were transfected with 50 pmol control (Ambion) or snrpb 
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(s74100, Ambion) Silencer Select siRNA using lipofectamine RNAiMAX (Invitrogen) as 
per the manufacturer’s protocol, and RNA was harvested 24 h post-transfection. 
 
Immunoprecipitation. For snRNA immunoprecipitation, NIH 3T3 cells were plated and 
transfected as performed for SmD3 transient knockdown. 23 h post-transfection, cells 
were harvested in lysis buffer (50 mM Tris-Cl pH 8, 150 mM NaCl, 0.5% Nonidet P-40) 
containing 1 mM phenylmethylsulfonyl fluoride and 1 × Protease Complete inhibitor 
mixture (Roche) and incubated on ice for 30 min. Cells were sonicated with five 5-
second pulses using a Branson Sonifier 250, incubating on ice for 20 sec between each 
pulse. Cell lysates were centrifuged at 15,000 × g for 30 min at 4°C to remove insoluble 
material. Cell lysates were immunoprecipitated using α-Sm Y12 antibody (ab3138, 
Abcam, 1:100) or IgG control. RNA was isolated from immunoprecipitated samples 
using TRIzol (Invitrogen) and reverse transcribed to cDNA using the SuperScript III 
First-strand Synthesis System for RT-PCR (Invitrogen) following the manufacturer’s 
instructions. Quantification of α-Sm immunoprecipitated snRNA expression relative to 
control IgG precipitated snRNA was performed by qRT-PCR. 
 
Superoxide Detection in vitro. Cells (8 × 104) were plated in 96-well opaque white 
microplates 24 h prior to treatment. Cells were incubated for 1 hr in reaction buffer 
containing 125 mM KCl, 10 mM HEPES, 5 mM MgCl2, 2 mM K2HPO4, and 5 µM 2-
methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazol[1,2-A]pyrazin-3-one, hydrochloride 
(MCLA) during continuous treatment (palmitate) or rinsed with PBS and incubated in 
reaction buffer immediately following treatment (doxorubicin). MCLA light emission was 
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quantified using a Tecan Infinite M200 microplate reader and iControl software. The 
photomultiplier was set with an integration time of 1000 ms. The MCLA signal was 
quantified in real-time or as an integral of the signal measured every 30 sec over 3 min.  
 
Real-time Reactive Oxygen Species Detection in vitro. Cells (5 × 104) were plated in 
12-well plates 24 h prior to CM-H2DCFDA loading. Cells were rinsed with PBS and 
incubated with PBS containing 0.5 mM MgCl2, 0.92 mM CaCl2, and 10µM CM-
H2DCFDA in the dark at 37°C for 10 min. Cells were then rinsed with PBS prior to 
various treatments in PBS containing 0.5 mM MgCl2 and 0.92 mM CaCl2. Mean 
fluorescence was quantified every 3 min with excitation/emission wavelengths of 
492/517 nm using a Tecan Infinite M200 microplate reader and iControl software. 
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Table 5.1: Primer/oligo sequences 
application primer/oligo primer/oligo sequence 
qRT-PCR snrpD3 forward 5'-CGGTGTGCCGATTAAAGTCT-3' 
 snrpD3 reverse 5'-TAACATGGGTGCGTTTTTCA-3' 
 snrpb forward 5'-TCTTCATCGGGACCTTCAAAGCCT-3' 
 snrpb reverse 5'-ACTCGCTTCTCTTCCCTTTCTGCT-3' 
 β-actin forward 5'-GGCTCCCAGCACCATGAA-3' 
 β-actin reverse 5'-GCCACCGATCCACACAGAGT-3' 
 luciferase exon 
1/intron forward 
5'-CAGGTAAGTATCAAGGTTCCCG-3' 
 luciferase intron 
reverse 
5'-CTCTTGGAAGGCAGATCTCTTG-3' 
 Snhg5 forward 5'-CAGTGAGTGAAATGCCAGCT-3' 
 Snhg5 reverse 5'-GACAGGTGCGTTTGAAGACA-3' 
 Nop56 forward 5'-TGAGGAACGGCTGTCTTTCT-3' 
 Nop56 reverse 5'-TCTTCAAGCGCTTCTTCTCC-3' 
 U60hg forward 5'-CCCTTTTTGCAGGTAAGGTG-3' 
 U60hg reverse 5'-AAAATCCTGTTGCCTGGATG-3' 
 RPL5 forward 5'-CCCGAACTACAACTGGCAAT-3' 
 RPL5 reverse 5'-CCGATGAACTTCTGCATTGA-3' 
 Snhg3 forward 5'-AAGAAGTCGCATCGGTACTGC-3' 
 Snhg3 reverse 5'-GGTGCAAGTCCCCAAAGTTA-3' 
 RPS2 forward 5'-GAAAATCATGCCAGTGCAGA-3' 
 RPS2 reverse 5'-CAAGACCAACGTGACCATTG-3' 
 EIF5 forward 5'-AGGCATGCTTGACACACATC-3' 
 EIF5 reverse 5'-CAGAGCCATTTTCCTTGTCC-3' 
 VWA5B2 forward 5'-GGCAGCAACCATGACTACCT-3' 
 VWA5B2 reverse 5'-TCTTGAGGAATGCACACAGC-3' 
 PKD1 forward 5'-GCTTCAGCAAGGTCAAGGAG-3' 
 PKD1 reverse 5'-TGGATCCATTCCTTCAAAGC-3' 
 36B4 forward (rat) 5'-CAGAGGTGCTGGACATCACAGA-3' 
 36B4 reverse (rat) 5'-AGTGAGGCACTGAGGCAACAG-3' 
rpL13a qRT-
PCR 
rpL13a exon 2 
forward 
5'-CATTGTGGCAAGCAAGTGCTACTG-3' 
 rpL13a exon 3 
reverse 
5'-AATGTTGATGCCTTCACAGCGCAC-3' 
 rpL13a exon 3 
forward 
5'-CGGAAGGTAGTCGTTGTGC-3' 
 rpL13a intron 3 
reverse 
5'-TGCTTGTCCAGAACTTAGGTC-3' 
 rpL13a exon 4 
forward 
5'-TTTCCTCCGAAAGCGGATGAACAC-3' 
 rpL13a exon 5 
reverse 
5'-GGATCCCATCCAACACCTTGAGG-3' 
 rpL13a exon 5 
forward 
5'-CCTCAAGGTGTTGGATGGGATCC-3' 
 rpL13a exon 6 
reverse 
5'-GCTTCAGCCGCACAACCTTG-3' 
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 rpL13a exon 6 
forward 
5'-CAAGGTTGTGCGGCTGAAGC-3' 
 rpL13a exon 7 
reverse 
5'-GGCCTTTTCCTTGCGTTTCTCC-3' 
 rpL13a exon 7 
forward 
5'-TGGGGTCGGGTGGAAATACC-3' 
 rpL13a exon 8 
reverse 
5'-CTTTTCTGCCTGTTTGCGTAG-3' 
 rpL13a forward 
(rat) 
5'-GGCTGAAGCCTACCAGAAAG-3' 
 rpL13a reverse 
(rat) 
5'-CTTTGCCTTTTCCTTCCGTT-3' 
snoRNA/miRNA
/tRNA reverse 
transcription 
U32a SLRT 
(hamster) 
5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCCAAGTCTC-3' 
 U32a SLRT (mouse) 5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCCGAGTCTC-3' 
 U33 SLRT 
(hamster) 
5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCCCAGCCTC-3' 
 U33 SLRT (mouse) 5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCACAGCCTC-3' 
 U35a SLRT 
(hamster) 
5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCTACTGGCA-3' 
 U35a SLRT (mouse) 5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCTCCTGGCA-3' 
 U50 SLRT 5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCGTCTCA-3' 
 U57 SLRT 5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCTGGATCAG-3' 
 U60 SLRT 5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCCCAAGC-3' 
 U21 SLRT 5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCGCCGCC-3' 
 U17b SLRT 5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCTTTTGT-3' 
 U64 SLRT 5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCACCTGTGG-3' 
 ACA28 SLRT 5’-GTGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCGTTTGTTA-3' 
 pre-miR-1224 SLRT 5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCCTGAGG-3' 
 pre-miR-1225 SLRT 5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCCTGGGG-3' 
 pre-miR-23a SLRT 5'-GCGTGGTCCCGACCACCACAGCCGCCACGA
CCACGCGGTCAG-3' 
 Glut RNA SLRT2 5'-CTCAGCGGCTGTCGTGGACTGGGTGCTGCC
GCTGAGTGGTTCCCTGA-3' 
snoRNA/miRNA
/tRNA PCR 
U32a forward 
(hamster) 
5'-AAGTCAGTGATGAGCAACAATCACCATC-3' 
 U32a forward 
(mouse) 
5'-GAGTCCATGATGAGCAACACTCACC-3' 
 U33 forward 5'-CAGCCTATGATGAAGCGATCTCCCAC-3' 
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(hamster) 
 U33 forward 
(mouse) 
5'-AGCTTGTGATGAGACATCTCCCACT-3' 
 U35a forward 
(hamster) 
5'-GGCACATGATGTTCTTATTCTCACGATGGT-
3' 
 U35a forward 
(mouse) 
5'-GGCACATGATGTTCTTATTCTCACGATGGT-
3' 
 U50 forward 5'-TCTATGATGATCCTATCCCGAAC-3' 
 U57 forward 5'-GATGAACGAACTTGGCCTGACCTTC-3' 
 U60 forward 5'-CCAAGCCTGTGATGAATTGC-3' 
 U21 forward 5'-GTAGTTGGTCCTTTGATTGCATGTGATGT-3' 
 U8 forward 5'-CCTTACCTGTTCCTCCTTTCG-3' 
 U8 reverse 5'-GAGCAACCAGGATGTTGTCA-3' 
 U13 forward 5'-TTTCTGGTTCATAAAGCGTGA-3' 
 U13 reverse 5'-TGTCAGACGGGTAATGTGC-3' 
 U17b forward 5’-AACGGGAGCTTAGGGCATT-3’ 
 U64 forward 5'-CTTTGGATTGGCCTCACAGT-3' 
 ACA28 forward 5'-AAGCAACACTCTGTGGCAGATGAA-3' 
 pre-miR-1224 
forward 
5'-GCGCTGTTTCAGCTCGCTTCTC-3' 
 pre-miR-1225 
forward 
5'-GTGCAGCCGGACTGACTGA-3' 
 pre-miR-23a 
forward 
5'-GGTTCCTGGGGATGGGATTTGATC-3' 
 Glu tRNA forward 5'-TAGTGGTTAGGATTCGGCGCTCTCAC-3' 
 Universal reverse 
primer 
5'-TCCCGACCACCACAGCC-3' 
 
 Universal reverse 
primer 2 
5'-GGCTGTCGTGGACTGGGTG-3' 
 
intron lariat 
PCR 
CHO rpL13a intron 
2 sense 
5'-GCTCTGAGACTTGACGGTCC-3' 
 CHO rpL13a intron 
2 antisense 
5'-CTCATCACTGACTTGCAGGC-3' 
 CHO rpL13a intron 
4 sense 
5'-ATCTCCCACTGGTGTTCGAG-3' 
 CHO rpL13a intron 
4 antisense 
5'-CAGATTCCCCATTCTCCATG-3' 
 CHO rpL13a intron 
5 sense 
5'-TCCTTCCCAGGTGATGCT-3' 
 CHO rpL13a intron 
5 antisense 
5'-TGGAAAGCTAGGCTTGCG-3' 
 CHO rpL13a intron 
6 sense 
5'-ATAATGCCACAGGCTCAGCT-3' 
 CHO rpL13a intron 
6 antisense 
5'-TCTGCCAGTCTACAGGTCCC-3' 
 mouse rpL13a 
intron 2 sense 
5'-TGTGAGATCAACCCATGCAC-3' 
 mouse rpL13a 
intron 2 antisense 
5'-CGAAAGATGGTGAGTGTTGC-3' 
 
snRNA PCR U1 forward 5'-GATACCATGATCACGAAGGTGGTT-3' 
 U1 reverse 5'-CACAAATTATGCAGTCGAGTTTCC-3' 
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 U2 forward 5'-TTTGGCTAAGATCAAGTGTAGTATCTGTTC-
3' 
 U2 reverse 5'-AATCCATTTAATATATTGTCCTCGGATAGA-
3' 
 U4 forward 5'-GCGCGATTATTGCTAATTGAAA-3' 
 U4 reverse 5'-AAAAATTGCCAATGCCGACTA-3' 
 U5 forward 5'-TACTCTGGTTTCTCTTCAGATCGTATAAAT-3' 
 U5 reverse 5'-AATTGGTTTAAGACTCAGAGTTGTTCCT-3' 
 U6 forward 5'-GCTTCGGCAGCACATATACTAAAAT-3' 
 U6 reverse 5'-ACGAATTTGCGTGTCATCCTT-3' 
 U11 forward 5'-GTGCGGAATCGACATCAAGAG-3' 
 U11 reverse 5'-CGCCGGGACCAACGAT-3' 
 U12 forward 5'-AACTTATGAGTAAGGAAAATAACGATTCG-3' 
 U12 reverse 5'-CCGCTCAAAAATTCGTCTCACA-3' 
 U4atac forward 5'-AGCGCATAGTGAGGGCAGTACTG-3' 
 U4atac reverse 5'-GCACCAAGGTAAAGCAAAAGCTCTA-3' 
 U6atac forward 5'-AGGTTAGCACTCCCCTTGACAA-3' 
 U6atac reverse 5'-TGGCAATGCCTTAACCGTATG-3' 
5’ RACE ROSAβgeo reverse 5’-CAAGGCGATTAAGTTGGGTAACGC-3’ 
PCR snrpD3 forward 5’-GCCGTGTAACGTTTGTGCC-3’ 
 snrpD3 reverse 5’-GGACACAGTTCTCTTCCAC-3’ 
 ROSAβgeo reverse 5’-CTCAGGTCAAATTCAGACGG-3’ 
siRNA snrpD3 sense 5’-GCUCAUUGAAGCAGAGGACUU-3’ 
 snrpD3 antisense 5’-GUCCUCUGCUUCAAUGAGCUU-3’ 
 scrambled control 
sense 
5’-AAGAUGAGCAUAGGAUGUU-3’ 
 scrambled control 
antisense 
5’-AACAUCCUAUGCUCA-3’ 
LNA/DNA oligos  GFP 5'-
+T*+C*+A*+C*+C*T*T*C*A*C*C*C*T*C*
T*+C*+C*+A*+C*+T-3' 
 U32a 5 ' 
+G*+C*+G*+G*+T*G*C*A*T*G*G*G*T*T*G*+
A*+T*+C*+T*+C 3'  
 U33 5' 
+T*+G*+G*+T*+A*G*T*G*C*A*T*G*T*A*G*+A
*+G*+T*+C*+A 3'  
 U35a 5' 
+T*+T*+A*+G*+C*C*T*T*T*G*G*C*A*T*T*+A*
+T*+C*+G*+G 3'  
 snrpD3 5'-
+T*+C*+T*+G*+T*A*T*G*T*G*A*C*T*G*
T*+G*+A*+T*+G*+T-3' 
RNase 
protection & 
FISH  
CHO U32 forward  
 
5’-TAC TGG GTA AGT TTC ATT CAG-3’ 
 
 CHO U32 reverse  5’-GTA ATA CGA CTC ACT ATA GGG AGG 
AAG GAG TCC AGG AGG G-3’ 
 CHO U33 forward  5’-GGG TGC CAT GGA GAA TGG G-3’ 
 CHO U33 reverse  5’-GTA ATA CGA CTC ACT ATA GGG AAG 
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 CGC TCT TAG CCC AGA TC-3’ 
 CHO U34 forward  5’-GCA AGC CTA GCT TTC CAC AG-3’ 
 CHO U34 reverse  
 
5’-GTA ATA CGA CTC ACT ATA GGG CTG 
GGA AGG AGG CTG GTG G-3’ 
 CHO U35 forward  5’-TTG CAG AGT GGT CTA GGT GG-3’ 
 CHO U35 reverse  
 
5’-GTA ATA CGA CTC ACT ATA GGG ACA TAT 
CCC CCT ATA CAG GAG-3’  
FISH mouse U3 forward  5’-TGT AGA GCA CCC GAA ACC AC-3’ 
 mouse U3 reverse  5’-TCC ACT CAG ACT GCG TTC C-3’ 
 mouse rpL13a intron 
1 forward  
5’-AAT TAA CCC TCA CTA AAAG GGA GCA 
ATA AAC AGG GTG GCT GT-3’ 
 mouse rpL13a intron 
1 reverse  
5’-GTA ATA CGA CTC ACT ATA GGG TCC 
TCA GAT GCT CAA GCA GA-3’ 
Primer 
extension  
U32a, U33: 18S 
target  
5’- GTAACTAGTTAGCATGCCAGAGTCTCG -
3’  
 U32a: 28S target  5’- GCTACGGACCTCCACCAGAG-3’  
 U35a: 28S target  5’-TCGTACTGAGCAGGATTACCATGGC-3’  
 Z17a, Z17b, U45a, 
U45b: 18S target  
5’- CCCGTCGGCATGTATTAGCTCTAG-3’  
 
 
*, phosphorothioate linkage; +, LNA residue 	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